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ABSTRACT.
There Is much controversy regarding the conformation of fibrinogen. 
Several models have been proposed ranging from a trinodular arrangement 
to a globular conformation. It has also been suggested that fibrinogen 
has a flexible structure where the shape of the molecule is influenced 
by its environment, one major factor being calcium concentration, In 
addition, although the importance of tightly bound calcium ions 
(kd - IpM) to the fibrinogen molecule is well established, the role of 
the larger number of low affinity sites (kd ~ ImM) is still a matter of 
some debate.
In this study, the two techniques of photosensitized radioactive 
surface labelling and photosensitized cross-linking were selected for 
development and assessment. This was done with a view to examining the 
conformation of fibrinogen in its native state and under different 
solvent conditions, with particular reference to the Influence of 
calcium.
The two techniques have been shown to have definite applications in 
their use as probes into the conformation of fibrinogen. Results derived 
using these methods support the view put forward by various authors that 
fibrinogen is a dynamic molecule having a flexible conformation and that 
the conformation adopted is dependent on solvent composition. Calcium 
concentration in the millimolar range is particularly significant and 
consequently so is the saturation of the low affinity binding sites 
which may well have a regulatory function. Experimentally two extreme 
conformations have been demonstrated, - a closed, compact structure at 
low calcium concentrations compared to a more open one at higher calcium 
concentrations. More importantly, the techniques used also show the 
subtle changes which occur within the molecule as the calcium 
concentration is raised, changes which may be more significant 
physiologically. The most important of these are the effect of calcium 
on the C-terminal parts of the Acx-chains and the D domains of the 
molecule.
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CHAPTER ONE
INTRODUCTION
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Part.. (1) ; Pibr.inagea. .and...Its Derivat.i%&s.
Fibrinogen is a soluble plasma glycoprotein and the 
precursor of fibrin monomers which in turn polymerize to form 
insoluble fibrin clots (see Figure 1-1). The protein thus forms 
part of a finely regulated system, the disruption of which 
results in various clinical conditions such as thrombosis and 
coronary artery disease, Consequently any advancement in the 
prevention and treatment of such diseases depends on the 
clarification of the various complex mechanisms of haemostasis.
Since fibrinogen plays a central role in blood coagulation, 
the understanding of the biochemistry of this protein has been 
avidly sought over the years (see eg., reviews by Doolittle, 
1981, 1984). Prior to stating the aims of this work, the main 
aspects of such research carried out on the fibrinogen molecule 
will be reviewed,
The..Chemistry of Fibrinogen
Fibrinogen is synthesized by the parenchymal cells of the 
liver and its molecular weight is approximately 340,000 ± 5%.
(As determined by analytical ultracentrifugation (Shulman, 1953; 
Caspary and Kekwick, 1957;) and light scattering (Katz et al,
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1952)). Human fibrinogen is a glycoprotein, containing about 3% 
carbohydrate. It constitutes 5% of the plasma proteins and the 
normal concentration found in human plasma is 9pH (or 3mg/ml). 
Fibrinogen differs from most other plasma proteins by its 
reduced solubility at low temperatures. Some of the 
physicochemical properties of human fibrinogen can be seen in 
Table l-(i) (Doolittle, 1981).
As can be seen from the schematic model of fibrinogen in 
Figure 1-2 (Gaffney, 1977), the molecule has a chemically 
symmetrical structure and is composed of three pairs of non- 
identical chains, Aa, Bg, and Y . The chains are all connected 
and held together by disulphide bonds to give a dimeric subunit 
formula of (AotsBjSsaVa) (Clegg and Bailey, 1962). The constituent 
reduced chains have been shown (by SDS-polyacrylamide gel 
electrophoresis) to have molecular weights of 67,000 (Aa), 
58,000 (B#), and 47,000 (V) (Gaffney and Dobos, 1971).
Full analysis of the primary structure of fibrinogen has 
been carried out and the complete sequence of each chain is 
known, ie. Aa (Doolittle et al, 1979), B)3 (Henschen and 
Lottspeich, 1977; Vatt et al, 1979), and V (Lottspeich and 
Henschen, 1977); the chains contain 610, 461 and 411 residues 
respectively (see Figure 1-3). Each of the three chains have 
certain distinct characteristics which are reflected in their 
amino-acid sequences. However, extensive homology has also been 
observed between the three non-identical chains, particulary
Table 1-(1) ; Same Physicochemical Properties of Human Fibrinogen. 
(Doolittle, 1981)
Molecular weight 340,000
Sedimentation coefficient (S;ao,w) 7.98
Translational diffusion coefficient
(D:ao, w)
20 X 10-^ cm® 3“’'
Frictional ratio (f/f.=.) 2.34
Partial specific volume (v) 0.715
Intrinsic viscosity (1^1) 0.25 dl/g
Per cent a-helix 33
Isoelectric point
(at ionic strength = 0.2)
5.5
Extinction (or absorbance) coefficient
(E l cm , s>ao)
15.1 - 15.5
Action of Thrombin
NH, 3HI
47
58
67COOH
I
COOH
]h
KEY
m  Aa CHAJJf 
S2S3 CHAIN 
O  Y CHAIN 
—  S-S BONDS
Figure 1~2’ Schematic model of a fibrinogen molecule. 
(From: Gaffney, 1977).
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281 S G P GOST G N R N P G S S G T G GST/GA T W K P G S S G P G S T G S W N S G S S
321 G T G S T G N 0 N P G S P R P G S T G T W N P G S S E R G S A G H W T S E S S V
361 S G S T G Q W H S E S G S F R P D S P G S G N A R p N NÜP lyNW G T F E E V S G N
401 V S P G T R R E Y H T E K L V T S K G D K E L R T c K E K V T S G S T T T T R R
441 S C S K T V T K T V I G P D G H K E V T K E V V T s E D G S D C P E A M D L G T
481 L S G I G T L D G F R H R H P D E A A F F D T A S T G K T F P G F F S P M L G E
521 F V S E T E S R G S E S G I F T N T K E S S S H H P G I A E F P S R G K S S S Y561 S K Q F T S S T S Y N R G D S T F E S K S Y K M A D E A G S E A D H E G T H S T
601 K R G H A K S R P V
B|3
1 Z G V N D N E E G F F S A R G H R P L D K K R E E A P S L R P A P P P I S G G G
41 Y R A R P A K A A A T Q K K V E R K A P D A G G C L H A D P D L G V L C P T G C
81 Q L Q E A L L Q Q E R P I R N S V D E L N N N V E A V D:,3 T S S S S Q F Y M Q L
121 L K D L W Û K R Q K Q V K D N E N V V N E Y S S E L E K H Q L Y I D E T V N S N
161 I P T N L B V L R S I L E N L R S K I 0 K L E S D V S A G M E Y C R T P C T V S
201 C NDI P V V S G K E C E E I I R K G G E T S E M Y L I Q P D S S V K P Y R V Y C
241 D M N T E N G G W T V I 0 N R Q D G S V D F G R K W D P Y K Q G F G N V A T N T
281 D G K N Y C G L P G E Y W L G N D K I S OEL T R M G P T E L L I E M E D W K G D
321 K V K A H Y G G F T V Q N E A N K Y Q I S V N K Y R G T A G N A L M D G A S Y L
361 M G E N»R T M T I H N G M F F S T Y D R D N D G W L T S D P R K Q C S K E D G G
401 G W W Y H R C H A A N P N G R Y Y W G G Û Y T W D M A K H G T D D G V V W M N W
441 K G S W Y S M R K M S M K I R P F F P Q Q
1 Y V A T R D N C C I L D E R F G S Y C P T T C G I A D F L S T Y G T K V D K D L
41 Q S L E D I L H Q V E N»K T S E V K Q L I K A I G U T Y N P D E S S K P N M I D
81 A A T L K S R K M L E E I M K Y E A S I L T H D S S I R Y L G E I Y N S N N G K
121 I V N L K E K V A Q L E A Q C Q E P C K D T V G I H D I T C K D C Q D I A N K G161 A K G S G L Y F I K P L K A N Q G F L V Y C E I D G S G N G W T V F G K R L D G
201 S V D F K K N W I Q Y K E G F G H L S P T G T T E F W L G N E K I H l I S T G S
241 A I P y A L R V E L E D W N G R T S T A D Y A M F K V G P E A D K Y R L T Y A Y
281 F A G G D A G D A F D G F D F G D D P S D K F F T S H N G M G F S T W D N D N D
321 K F E G H C A E Q D G S G W W M N K C H A G H L N G V Y Y G G G (T,,Y,,3  K A S T P
361 N G Y D N G I C,,w,.A.iT,,W)K T R W Y S M K K T T M K I I P F N R L T I G E G 0 G H
401 H L G G A K 0 A G D V
KBl
A = Ala, C = Cys, D = Asp, E = Glu, F = Phe, G = Gly, H = His, I = lie,
K = Lys, L = Leu, M = Met, H = Asn, P = Pro, Q = Gin, R = Arg, S = Ser,
T = Thr, V = Val, V = Trp, Y = Tyr, Z = pyrrolidonecarboxylic acid,
♦ = site of carbohydrate attachment,
Figure 1-3: Complete amino-acid sequence of the Aa, BB, and y chains 
of human fibrinogen. (From: Furlan, 1984).
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between the Bj3 and Y-chalns. It has thus been suggested 
(Doolittle, 1976) that all three chains are descended from a 
common ancestor. These similarities and differences bear out on 
the overall structural features of the fibrinogen molecule.
As seen earlier (Figure 1-2), disulphide bonds are very 
important with respect to the structural integrity of the 
molecule, There are 58 cysteine residues in human fibrinogen 
(Henschen, 1964), but no free SH-groups (Loewy et al, 1961). It 
was thus concluded that all these residues are involved in 
disulphide bridges (Henschen, 1964; Henschen and Blomback 
1964;). Of the 29 disulphide bridges, three are involved in 
linking the dimeric halves of the fibrinogen molecule together 
(Blomback et al, 1976), seven connect individual subunit 
polypeptides within each half of the molecule, and the remaining 
disulphide bridges form intrachain bonds (Gardlund et al, 1977; 
Henschen, 1978;). The cysteine residues have been found to be 
concentrated in three clusters along each polypeptide chain (as 
illustrated by Henschen et al, 1982). The amino terminal of the 
molecule is held tightly together in a dimeric form and this is 
known as the N-terminal disulphide knot (ie. N-DSK or Hil-DSK, 
obtained from cyanogen bromide cleavage of human fibrinogen).
The latter was found to contain all three inter-dimeric half 
bridges, namely one disulphide bond between the two Aa-chains 
and two disulphide bonds between the Y-chains (Gardlund et al, 
1977).
It is well established that human fibrinogen contains four 
heterogenous carbohydrate side chains, namely the neutral 
hexoses, mannose and galactose, the hexosamine, N-acetyl- 
glucosamine, and sialic acid as the charged, terminal, 
carbohydrate (see review by Haberli, 1984), Each Bj3 and %-chain 
carries one sugar side chain, M-glycosidically linked to 
asparagine residue number 364 of the Bj3-chain (Topfer-Petersen 
et al, 1976) and number 52 of the Y-chaln (Kowalska-Loth et al, 
1973). The role of the carbohydrate moieties is not very clear, 
however various authors have shown that the removal of sialic 
acid enhances the clotting of fibrinogen (Chandrasekhar et al, 
1962; Martinez et al, 1977, 1978;).
In addition to its other properties, fibrinogen also 
exhibits a certain degree of molecular heterogeneity which can 
be ascribed to a variety of causes (see Table l-(ii)). 
Investigation of plasma fibrinogen subfractions (I-l to 1-9) of 
varying solubility (Mosesson and Sherry, 1966) have led to the 
recognition that a major proportion of circulating fibrinogen is 
composed of coagulable species that have undergone varying 
degrees of proteolytic attack resulting in the cleavage and 
release of C-terminal Aa-chain peptides (Mosesson et al, 1972a). 
In addition, three major types of Aa-chains have been identified 
that differ with respect to their fibrinopeptide A composition 
(Blomback et al, 1966). One such type (Y) exhibits deletion of 
the amino-terminal alanine, whilst another type (AP) contains a 
phosphorylated serine residue in position 3, Heterogeneity of
Table l-(il) : Summary of the Known Major Variants of Human Plasma 
Fibrinogen Chains. (Mosesson, 1983),
Terminology Variation Essential struct­
ural difference
Comment
Fibrinopeptide A 
structure
AP phosphorylated
serine
lacks HHa-Ala
unknown
functional
difference
Aa/2, Aof/4 
Aoi/6. . . etc;
Aa/chain size lack of peptides 
containing C-terminal 
regions due to pro­
teolysis and release 
from parent molecules
loss of
peptides
results in
delay in
fibrin
aggregation
rate
B^ L.
B0r
K-1
Ï-2
B^ chain carbo­
hydrate content 
(sialic acid)
K chain carbo- 
hrdrate content 
(sialic acid)
2 sialic acid 
residues/chain
1 sialic acid 
residue/chain
2 sialic acid 
residues/chain
1 sialic acid 
residue/chain
desialation 
Venhances 
fibrin 
aggregation 
rate
Y'
Y chain amino 
acid sequence 
(chain size)
C-terminal 
sequences differ
Y' larger than Y
unknown
Afunctional
difference
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the (le. BJ3i_. and B|3r ) and Y (le. Y~1 and Y-2) chains has been 
observed regarding the sialic acid content of their carbohydrate 
moiety (Gati and Straub, 1978). As well as the latter 
differences in the Y-chain, another class of functionally 
equivalent Y-chains was reported (ie. Y ') by Mosesson et al, 
(1972b). The Y' chain is longer that that from the major 
population of Y-chains by virtue of amino-acid sequence 
differences in the respective C-termini.
Fibrinogen in Coagulation,
As seen earlier (Figure 1-1) fibrinogen plays a major role 
in the coagulation cascade and is the natural substrate for 
thrombin, the final proteolytic enzyme in this chain of events. 
By cleaving only about 1% of the mass of fibrinogen, thrombin 
initiates a self-assembly process and the formation of an 
insoluble fibrin clot.
In their review regarding the structure and interaction of 
fibrin, Hermans and McDonagh (1982) divide the process of fibrin 
assembly and cross-linking into four steps, namely ;
(1) Activation of fibrinogen by thrombin,
(2) End-to-end polymerization of monomeric fibrin to form 
protofibrils,
(3) Lateral association of protofibrils to fibrin fibres,
(4) Covalent cross-linking of fibrin by factor Xllla.
—  6 —
Each of these stages will now be discussed in further detail.
Thrombin has been shown to proteolytically attack the Act and 
B#-chain pairs of fibrinogen, thus releasing four negatively 
charged peptides from the molecule, termed fibrinopeptide A 
(from each Act-chain) and fibrinopeptide B (from each B#-chain> 
respectively (Bailey et al, 1951; Lorand, 1951;). Enzymic attack 
occurs at the N-termini of the chains, at two sets of Arg-Gly 
bonds, ie. (Aa 16-17 and B|3 14-15) and the resulting thrombin- 
modified molecules are denoted as fibrin monomers. (The modified 
chains of these species are termed a, ^ and Y), Fibrinopeptide A 
is released faster than the B peptide (Blomback and Blomback, 
1972) and two molecular models have been proposed to explain 
this difference in cleavage rates, - a sequential and a 
competitive model. According to the former mechanism, cleavage 
of the A peptide from fibrinogen initiates ordered alignment of 
desA-fibrin monomers which in turn induces a specific 
conformational change in the fibrinogen molecule. This then 
results in an increased susceptibility of the B^ peptide bond to 
thrombin action (Blomback et al, 1978). In contrast, the 
competitive model assumes full access of thrombin to the Aa and 
Bj3-chain cleavage sites, however in this mechanism it is 
suggested that peptide A is released faster than peptide B 
because the rate constant for the hydrolysis of the specific 
Arg-Gly bond in the Aa-chain is greater than that for the B#- 
chain (Martinelli and Scheraga, 1980). It has also been shown 
that desA-fibrin monomers (prepared by use of the snake venom
reptilase which only releases the A peptide) are sufficient for 
the initiation of fibrin assembly (Blomback and Blomback, 1972).
As well as reducing the excess negative charge on fibrinogen 
molecules, the release of fibrinopeptides exposes definite 
contact sites which are masked in intact fibrinogen. 
Polymerization of the fibrin monomer units then occurs 
spontaneously (Ferry, 1952) to form a non-covalently bonded gel 
(steps (2) and (3)), and the polymer can then be covalently 
cross-linked by a calcium-dependent enzyme, factor Xllla, itself 
activated by thrombin (step 4).
The first step in this process involves the end-to-end 
polymerization of monomeric fibrin to long strands two molecules 
in diameter which are called protofibrils (Fowler et al, 1981; 
see figure 1-4(a)). The contacts that hold the monomers together 
are: (a) longitudinal, between the terminal D nodules of 
fibrinogen (ie, DD-long contacts), and (b) staggered, lateral 
contacts between the terminal and the central E nodule (ie. DE- 
stag contacts). The model shown in figure 1-4(a) assumes 'face- 
to-face' attachment of interacting fibrin monomers and 
accomodates the observation that two-stranded protofibrils are 
formed in the course of fibrin polymerization as a distinct 
structural intermediate.
Thus both pairs of complementary contact sites are saturated 
within a double stranded protofibril and the latter is closed
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with respect to lateral growth. The existence of another 
intermolecular contact site, ie. DD-lat (see Figure 1-4(b)) was 
thus postulated and involves the terminal D domains. These 
contacts are responsible for lateral association (step 3) of 
protofibrils to fibres. The latter form as a network and 
consequently the final fibrin solution is a gel. The binding 
affinity of the DD-lat polymerization sites is weak, the latter 
being deduced from the observation that protofibrils do not 
begin to form fibres until they have grown to exceed some 
critical length. The existence of this contact site is still 
speculative and Erickson and Fowler (1983) suggest an 
alternative possibility, ie. that adjacent protofibrils could 
also be 'staggered' (and not in register as in Figure 1-4(b>), 
in which case additional lateral contacts between the D and E 
nodules (ie. DE-lat) could also occur.
Alternative models for fibrin polymerization have also been 
put forward (Olexa and Budzynski, 1980). The latter workers 
assume 'face-to-back' alignment of fibrin monomers and all 
laterally packed fibrin strands face the same direction. Thus, 
by this mechanism, the two-stranded protofibril would not be a 
distinct structural intermediate because a third and succeeding 
strands could be added using the same DE-stag contacts which are 
always exposed on the free edge. This type of 'open* 
polymerization is not compatible with the evidence put forward 
by various authors, showing the two-stranded protofibrils to be 
the predominant polymer species at early times of assembly
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(Ferry, 1952; Krakow et al, 1972; Hantgan and Hermans, 1979; 
Hantgan et al, 1980;).
The final stage in fibrin formation is the cross-linking of 
fibrin via the formation of isopeptide bonds catalysed by a 
calcium-dependent enzyme, factor Xllla (Lorand, 1972).
However before this can be achieved, generation of the 
active enzyme from the fibrin stabilizing factor zymogen (factor 
XIII or a^bs) must be accomplished by unmasking of the active 
centre residue cysteine on the catalytic subunit. This occurs in 
two distinct stages and requires both thrombin and calcium ions 
(Lorand and Konishi, 1964). First thrombin removes an amino- 
terminal peptide fragment from the 'a* subunits of the a-^ bs 
zymogen. This, however, still leaves the subunits heterologously 
associated as a^'bz (ie. factor XIII') which is not sufficient 
for generating transamidase activity. Expression of the latter 
is dependent on calcium ions which cause the release of non- 
catalytic b subunits (Curtis et al, 1974), as well as the 
conversion of the as>' to as*. The latter represent the 
functionally competent enzyme, factor XIIla.
Factor XIIla then forms intermolecular Y-glutamdnyl-e-lysyl 
cross-links between fibrin molecules. Only selected lysine and 
glutamine residues can take part in the cross-linking reaction 
and up to six isopeptide bonds may be introduced per mole of 
fibrin monomer under optimum conditions.
- 1 0 -
A pair of cross-links is first formed between the C-terminal 
portions of the %-chains of adjacent fibrin molecules to form 
dimer (Chen and Doolittle, 1971). Thus a glutamine (residue 
397) and a lysine (residue 405) on one %-chain undergo 
reciprocal cross-linking with those from another %-chain.
During prolonged action of factor Xllla on fibrin, a-chains 
also become cross-linked to other a-chains, leading to-the 
formation of a-chain multimers (McKee et al, 1970). There may be 
2-4 potential cross-links distributed among the a-chains and it 
has been suggested that the a-chain cross-link sites are located 
in the central portion of this chain (Fretto et al, 1978). In 
fact, Doolittle et al (1979) showed that specific a-chain 
glutamine residues incorporate radioactive substitute donors 
(ie. T^C-glycine ethyl ester) under the influence of factor 
XIIla, namely residues 328 and 366 in the middle region of the 
a-chain.
The ■Di.g.e.gtioa of .Fibrinogen
Although the formation of blood clots is essential, a 
mechanism for their removal when they are no longer needed or 
for dissolving any fibrin in the general circulation is also 
important. Thus a fine biochemical balance must be struck in 
order to maintain intravascular fluidity while simultaneously 
retaining the capacity to seal any leaks in the system,
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Plasmin (molecular weight : 85,000, derived from the 
zymogen, plasminogen, ) is the key enzyme in the fibrinolytic 
system and has a directly opposite effect to that of thrombin. 
The conversion of plasminogen to plasmin (see review by Kosow, 
1976) may be catalyzed by various proteases such as those found 
in many tissues (tissue activators), in blood (blood/vascular 
activators), or body fluids eg. urine (urokinase). Various 
strains of streptococci produce the extracellular protein, 
streptokinase, which is also capable of activating human 
plasminogen. The zymogen may also undergo spontaneous activation 
which is accelerated by glycerol, di- and tri- ethylene glycols. 
Although both plasmin and thrombin are serine proteases, they 
act on the same substrate, fibrinogen, with remarkably different 
specificities. In effect thrombin promotes the construction of 
blood clots whilst plasmin plays a key role in their removal.
Plasmin preferentially catalyzes the hydrolysis of peptide 
bonds between the carboxyl-group of lysine or arginine and the 
amino-group of another amino acid. The interaction between 
fibrinogen and plasmin was first studied by Hussenzweig (1961) 
who used DEAE-cellulose column chromatography to seperate five 
•final' fibrinogen degradation products after prolonged lysis by 
the enzyme. The author called these fractions A, B, C, D and E. 
However, on the basis of column chromatography and gel 
electrophoresis studies, Harder et al (1969) proposed an 
asymmetric cleavage model of fibrinogen degradation, the main 
factors of which are generally accepted to date. Figure 1-5
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shows the major aspects of this sequence of degradation 
reactions and the products produced.
Breakdown commences by the degradation of the polar 
C-terminals of the Aoc-chains and the products of this initial 
step are denoted as fragments X. The latter represent a mixture 
of several molecular species in which the C-terminal two-thirds 
of the Aa-chains have been degraded to various extents, followed 
by sequential degradation at the I-terminals of the Bj3-chains in 
’late’ fragment X species. Molecular weights of the X fragments 
vary from 240,000 to 337,000 (Furlan and Beck, 1972; Liu et al, 
1986;). Cottrell and Doolittle (1976) indicated that the 
earliest plasmic cleavage occurs at Aa 583 (lysine) - 584 
(methionine), with the release of a peptide (molecular weight: 
2,859) containing the C-terminal 27 amino-acid residues of the 
Aa-chain. Other sites of plasmic cleavage on the latter chain 
exist at Aa 424-425 and Aa 206-207, whilst cleavage of-the Bj3- 
chain occurs at BJ3 42-43 (Liu et al, 1986).
Mext, asymmetric interdomainal attack in the centre of one 
of the three stranded ropes of fragment X occurs. The result is 
fragment Y (molecular weight : 150,000-160,000) and fragment D 
(molecular weight t 70,000-95,000). Further interdomainal 
cleavage of fragment Y then occurs and this results in a second 
fragment D and another digest product, fragment E (molecular 
weight : 50,000-60,000). Thus, during extensive plasmin
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Elgurs 1-.5! Scheme of fibrinogen digestion by plasmin. 
(Latallo, 1973).
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digestion, two moles of the 'core' fragment D and one mole of 
'core' fragment E are produced from one mole of fibrinogen.
Gaffney (1973) showed that the end-products of digestion of 
non-crosslinked fibrin are electrophoretically indistinguishable 
from those resulting from the digestion of fibrinogen, However, 
prolonged lysis of cross-linked fibrin produces an additional 
major fragment, namely %-cross-linked D-dimer (Kopec et al,
1973). Fragment E binds to D-dimer with high affinity to form a 
D-dimer - E complex and the latter has been isolated from the 
digests of cross-linked fibrin (Hudry-Clergeon et al, 1974).
Three molecular forms of fragment E (ie. Ei , Es, Es) have 
been isolated (Olexa et al, 1981), The fragment corresponds to 
the central dimeric domain of fibrinogen, sharing all H-termini 
of the six chains and also corresponds closely to the dimeric 
disulphide knot (ÎT-DSK) isolated by cyanogen bromide 
fragmentation of fibrinogen. In their studies on the stimulation 
of fibrinogen synthesis in cultured rat hepatocytes by 
fibrinogen and its degradation products, D and E, Qureshi et al 
(1985) showed that only fragment E was a specific stimulator of 
fibrinogen biosynthesis. These workers thus suggested that the 
fragment plays an important role in maintaining normal levels of 
plasma fibrinogen.
Each fragment D consists of the remnants of the Aa, and 
%-chains of fibrinogen and corresponds to each of the outer
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terminal domains of the native molecule. Several fragment D 
species have been recovered from plasmic digests in the absence 
of calcium ions (Furlan et al, 1975; Takagi and Doolittle, 1975; 
Lawrie et al, 1977;). All these species contain the same a and # 
remnants (molecular weights : 10,000 and 45,000 respectively), 
however the heterogeneity of the fragment was shown to be caused 
by the gradual degradation of the %-chain at its C-terminal end. 
The %-chain molecular weight was thus found to vary from 39,000 
to 13,000.
It was also shown (Gaffney and Brasher, 1973) that the 
D-dimer produced by digestion of cross-linked fibrin is 
comprised of %-chains corresponding to those found in the 
earliest forms of fragment D, as distinct from later forms. This 
information was not only consistent with the positioning of the 
%-chain cross-linking site close to the C-terminus of this 
chain, but also confirmed that lysis by plasmin of fragment D 
occurred at the C-terminal of the ï-chain.
At a physiological calcium concentration, Haverkate and 
Timan (1977) showed that only the largest (early) species of 
fragment D is produced, indicating that calcium ions protect 
this fragment against further attack by plasmin. The authors 
designated this fragment D species as D(cate) (molecular weight: 
93,000) and found that after removal of calcium ions with BGTA, 
the fragment is further degraded to a final fragment D (ie. 
D(EGTA), molecular weight : 80,000), by breakdown of the %-chain
- 15 -
from 38,000 to 25,000. On the basis of these findings, Haverkate 
and Timan also suggested that D(cate) represents the 
physiologically important fragment D type. Haverkate et al 
(1979) also showed that D(cate) exhibits anti-clotting activity, 
whereas shortening of the %-chain remnants (as in D(EGTA)) leads 
to the loss of such activity. The authors thus concluded that 
the integrity of this Y-chain remnant (molecular weight: 13,000) 
is essential for the anti-clotting properties of fibrinogen 
fragments D.
In 1982 Hieuwenhuizen et al (reference (a)) prepared an 
additional fragment D, D(int), which had a V-chain molecular 
weight of 29,000, but which possessed no anti-clotting 
properties. Consequently these authors suggested that the anti­
clotting properties of D(cate) reside in the V 9-kDalton stretch 
that is absent in D(int).
Cross-linking patterns (using the chemical agents, dimethyl 
suberimidate, dimethyl adipimidate, and tetranltromethane) of 
fibrinogen fragment D prepared either in the presence of calcium 
ions or EDTA were shown to be consistently different from each 
other (Britton et al, 1982). Fragment D(EDTA) showed much 
intermolecular cross-linking indicating that the loss of the 
C-terminus of the Y-chain remnant results in this fragment D 
adopting a more open conformation. Heither the addition of 2 M 
urea or EDTA to fragment D(Ca^+) altered its cross-linking 
pattern, suggesting that the conformational change follows
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cleavage of a plasmin-susceptible bond which is normally 
protected by the presence of calcium ions. These results were 
supported by further studies from workers in this laboratory 
(Britton et al, 1983).
CalQlum. .and Fibrinogen
Ionized calcium (Ca^^) is the biologically active fraction 
of total serum calcium, the remainder being bound to plasma 
proteins and anions (see Table 1-iii). It is this free calcium 
that is necessary for several basic physiological functions 
which include blood coagulation. Ionized calcium also plays a 
principal role in maintaining the structure and physiological 
properties of fibrinogen (see review by Kemp, 1984).
Ly and Godal (1973) demonstrated that the presence of 
calcium provided protection of fibrinogen against moderate 
dénaturation by heat or alkali, whilst Komenko and Belitser
(1963) showed that calcium protects the molecule against |
{proteolytic degradation by trypsin. In addition, Marguerie I
I(1977) demonstrated that the molecule is more resistant to the |
initial rate of attack by plasmin in the presence of calcium and 3
I
also that fibrinogen was more stabilized against temperature and |iacid dénaturation in the presence of this cation. Î
Table l-(lil) ; Distribution of Calcium (mmol/L) in Normal Plasma.
(From : Ganong's Review of Medical Physiology, 1983)
DIFFUSIBLE
Ionized calcium (Ca++)
Complexed to HCO3 , citrate, etc.,
1.18 
0. 16
1.34
NON-DIFFUSIBLE (protein-bound) 1. 16
Bound to albumin 0.92
Bound to globulin 0.24
TOTAL PLASMA CALCIUM 2.50
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In their studies regarding the effect of calcium ions on the 
polymerization of fibrin monomers, Endres and Scheraga (1972) 
showed that calcium is required as a catalyst for this process. 
In order to explain this catalytic property, the authors 
suggested that calcium ions bind to specific binding sites in 
fibrinogen and the fibrin monomer. Marguerie (1977) proposed 
that the structural features of fibrinogen are related to the 
existence of such calcium binding sites in the molecule. The 
calcium binding properties of fibrinogen were further 
investigated by Marguerie et al (1977) by means of equilibrium 
dialysis studies on bovine fibrinogen. These studies revealed 
that the molecules did indeed possess a number of specific 
binding sites for calcium. The authors showed that at pH 7.5 
fibrinogen has 3 binding sites of high affinity (kd = 2 x 10'"®M) 
and several (14-20) binding sites of low affinity (kci = IQ-^M). 
Marguerie and co-workers found that the sites of low affinity 
were eliminated at 10“^M MgCl^, and thus suggested that these 
are not specific and are due to weak interactions. The authors 
also showed that the three sites of high affinity are not 
identical since one of these sites was eliminated at pH 6.0. 
Several other investigators have shown that fibrinogen from 
other species (including human fibrinogen) also contain high and 
low affinity calcium binding sites (Van Ruijven-Vermeer et al, 
1978; Kemp et al, 1983;).
As seen earlier, calcium plays an important role in 
regulating the digestion of fragment D by plasmin (Haverkate and
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Timan, 1977). A number of studies have Indicated that each 
fragment D contains one high affinity calcium binding site 
(Lawrie and Kemp, 1978; Purves et al, 1978; Nieuwenhuizen et al, 
1979;). Purves et al (1978) suggested that calcium ions protect 
D(cate) by holding down a Y-chain loop, about 100 residues from 
the C-terminal end of this chain, to the remainder of fragment 
D, whilst Lawrie and Kemp later (1979) proposed that the calcium 
binding site is located within the Y-chaln, forming an 
intrachain bridge near the C-terminus of this chain.
Precisely what residues are involved in the calcium binding 
site on fragment J> is still a matter of some debate. D(cate) 
(Y-chain molecular weight ; 38,000), in contrast to D(EGTA) 
(Y-chain molecular weight : 25,000), is capable of binding one 
calcium ion per molecule. In their isolation of D(int) (Y-chain 
molecular weight ; 29,000) Nieuwenhuizen et al (1982a) found 
that this fragment retains its calcium binding properties. The 
authors thus proposed that the calcium binding site of D(int) 
(and D(cate)) is directly dependent on the 4-kDalton portion of 
the Y-chain (residues 303-321/356) which is present in D(int) 
but not in D(EGTA). This conclusion was supported by the 
findings of Varadi and Scheraga (1986) who, on the basis of 
their equilibrium dialysis binding studies, proposed that 
segment Y 305-355/356 plays a crucial role in calcium binding.
Dang et al (1985) used terbium fluorescence as a means to 
locate the fibrinogen calcium binding site on fragment D. It is
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well established that the trivalent lanthanide, terbium, 
competitively inhibits the binding of calcium to the protein; 
binding of terbium to a calcium site results in the enhancement 
of terbium fluorescence by resonance energy transfer from 
tryptophan residues. By employing this elegant method of 
detection, the authors narrowed down the location of the 
D domain calcium site to lie between residues 311-336 of the 
Y-chain,
However, in their recent studies concerning the role of 
disulphide bonds near the calcium binding sites in fibrinogen, 
Procyk and Blomback (1987) reported that Y 326-339 is the 
important region of this chain for the binding of calcium.
Nieuwenhuizen et al (1979) originally found one high 
affinity site to have a different dissociation constant 
(kci = 3.2 X 10”®M) from the other two (k.d = 9 x 10"*M). However, 
when the latter group of workers re-assessed their data in 1981, 
they concluded that the molecule had three identical binding 
sites (kd = 1.9 X 10"®M). This result is in contrast to that of 
Kemp et al (1983) who found one of the sites to have a higher 
affinity (ka = 4.6 x lO"?#) than the other two (ka =
3 X 10“®M).
The location of the third site is also contentious. 
Fibrinogen contains two fragment D entities; thus if there are 
three tightly bound calcium ions and the symmetry of the
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fibrinogen molecule is taken into account, the remaining calcium 
ion must form a bridge between the two halves of the molecule. 
Marguerie (1977) observed that the initial rate of plasmin 
attack on fibrinogen is lower in the presence of calcium. 
According to the author, calcium influences the cleavage, of the 
first one or two bonds involving the initial attack on the Aa- 
chains at the C-termini. This thus implicated the Aa-chains in 
calcium binding. This proposal, albeit tempting, was however 
disputed by two seperate sources.
Nieuwenhuizen and Gravesen (1981) showed that there was no 
difference in the number of calcium ions bound by fibrinogen and 
fragment X, thus precluding the involvement of the C-terminal 
parts of the Aa-chains in calcium ion binding. This view was 
supported by Ross and Kemp (1981) who found no evidence of 
calcium binding in their studies of calcium ion release during 
the early plasmin digestion of intact fibrinogen. Further 
studies by Nieuwenhuizen et al (1982b) supported the view that 
the C-terminal parts of the Aa-chains are not involved in 
calcium binding and suggested that the third high affinity site 
may be located in the central domain of the molecule. In fact 
later studies by workers from this laboratory (1983) concerned 
the purified fragments of fibrin(ogen) prepared by plasmin 
digestion or CNBr degradation. The authors found that Es (late 
fragment E) did not bind calcium, however a similar cyanogen 
bromide cleavage product did bind calcium, albeit with a lower
- 2 1 -
affinity (K.=, == 10"*%) than that which these workers had 
previously observed in intact fibrinogen.
However Marguerie supported his earlier proposals by studies 
done by himself and Ardaillou in 1982. The authors found that 
molecules with intact Aa-chains possessed three high affinity 
binding sites whereas those fibrinogen molecules with partially 
degraded Aa-chains exhibited only two sites, and thus suggested 
that the integrity of the chain is required for interaction 
between the protein and cation, Thus two totally different 
proposals concerning the location of the third high affinity 
site exist. Some of these differences may be attributed to the 
lability of the C-terminal parts of the Aa-chains.
For calcium ions to play a regulatory role in fibrinogen 
function, the dissociation constant of binding sites on the 
molecule should be in the region of the physiological calcium 
concentration (ie. approximately 10~®M). The reported 
dissociation constants for the different types of affinity sites 
thus suggest that the high affinity sites (Ka “ 10“®M> are an 
integral part of the structure of fibrinogen since their 
dissociation constant is significantly lower than the free Ca+^ 
concentration in plasma (Hardy et al, 1983). However the low 
affinity sites (Kd 10"'^M) could play an important role in 
physiological phenomena. Little information is available 
regarding the latter sites apart from the fact that they are 
more numerous and less specific for calcium (Marguerie et
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al, 1977). However since their dissociation constant is close to 
the physiological calcium concentration it is highly likely that 
calcium ions binding to these sites may have a regulatory 
function such as that concerned with fibrin polymerization.
Ihe. ..Shape .of Eibcinogen
The overall structure of fibrinogen is still unknown and 
remains a controversial subject. Several conflicting models have 
been proposed ranging from a trinodular arrangement (Hall and 
Slayter, 1959) to a globular conformation (Koppel, 1966).
A comprehensive review of the main models put forward to 
date and the different methods used by various groups of workers 
for the determination of the latter, will be discussed in 
Chapter 4. However in order to put the voluminous amount of 
information into perspective, a summary of the techniques used 
and the principal basic structures proposed by various workers 
(in chronological order) can be seen overleaf in Table l-(iv).
Table l-(iv) : Proposed Models of Fibrinogen Conformation.
AmQR..<S). SHAPE.
Hall and Slayter Electron microscopy
(1959) (shadow casting)
Trinodular
Koppel (1966) Electron microscopy 
(negative staining)
Globular
(pentagonal dodecahedron)
Pouit et al 
(1972)
Electron microscopy 
(negative staining)
Globular
(some flexibility)
Bachmann et al 
(1975)
Electron microscopy 
(freeze etching and 
shadow casting)
Cylindrical rod 
(some flexibility)
Hudry-Clergeon 
et al (1975)
Electron microscopy 
(negative staining)
Mon-compact, flexible 
sphere
Marguerie et al 
(1975/76)
Neutron small angle 
scattering
Ellipsoid or 'banana' 
shape
Doolittle et al 
(1977)
Computer simulation Trinodular
Mueller and 
Burchard (1978)
Light scattering Flexible rod
Fowler and 
Erickson (1979)
Electron microscopy 
(shadow casting and 
negative staining)
Trinodular
Lederer (1979) Small angle X-ray 
scattering
Flexible 'sausage'
Serralach et al 
(1979)
Data analysis Flexible structure
CCONT/-]
AUTHOR(SX TE.CHfi.LQM S H A M
Estis and 
Haschemayer (1980)
Electron microscopy 
(negative staining)
Flexible rod
Hantgan (1981/82) Steady state 
fluoresence 
polarization
Flexible structure
Mosesson et al 
(1981)
Scanning transmission 
electron microscopy 
(STEM)
Flexible trinodular
Veisel et al 
(1981/85)
Electron microscopy 
(rotary shadowing and 
X-ray crystallography)
Heptad model
Williams (1981) Electron microscopy 
(rotary shadowing and 
negative staining)
Trinodular
Plow and 
Edgington (1982)
Immunochemical
analysis
Flexible trinodular
Larsson et al 
(1987)
Dynamic laser light 
scattering (DLS)
Flexible structure
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Part (2): Photosensitized Radl.aaatlze_.laJballij[is..and-.EhQ.t.Q-.. 
sensitized. Cross-Linking.. 
PhotQ.Qxidation techniques
The use of photoaffinity labelling to explore the topography 
of proteins was originally proposed by Singh et al (1962). One 
approach involves the affinity labelling of ligand binding sites 
in the study of their structure-function relationship. This can 
be done by photoreactive probes incorporated into a compound 
normally binding to the site. Location of the amino-acid 
residues near or in the active site can thus be obtained by 
degrading the protein and identifying the labelled fragments. 
Examples of such sytems studied include the interaction of 
substrates and cofactors with enzymes, and hormones with their 
receptors (see review by Jori and Spikes, 1978).
However an alternative approach involves the use of 
photooxidation techniques. Photooxidations can be classified 
into two main groups, ie. direct oxidations in which the excited 
molecule is oxidised directly, and sensitized oxidations in 
which the initially excited molecule or 'sensitizer' indirectly 
promotes the oxidation of another molecule. Many processes 
induced by X-rays and %-rays involve direct oxidations, however 
it is the sensitized mode of oxidation that is of relevance in 
the context of this work.
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Dye-sensitized photooxidations can occur according to two 
different mechanisms (Meier, 1970), ie:
(a) Hydrogen abstraction (Type I), or
(b) Oxygen transfer (Type II).
(See Figure 1-6).
In type I the excited sensitizer interacts with another 
molecule directly, usually by transfer of a hydrogen atom or an 
electron. In the second class of reaction (type II) the 
sensitizer triplet (see Figure 1-7) reacts with oxygen, most 
commonly by energy transfer, to give an excited electronic state 
of oxygen, singlet oxygen, which reacts further with various 
acceptors in solution (Foote, 1968; Foote, 1976). The lifetime 
of the most important singlet oxygen species CAg) is 
approximately 2 pseconds in neutral aqueous solutions and 
several orders of magnitude greater in non-polar solvents 
(Foote, 1976); it is characterized by an energy of 22kcal above 
the ground state. Dyes with reactive triplet states such as 
fluorescein usually react in the presence of air according to 
the oxygen-transfer mechanism.
Dye photosensitized oxidation has been used to modify 
certain amino-acids in proteins. (Ray, 1967; Vesthead, 1972), 
This was done with the aim of identifying critical residues at, 
for example, the catalytic sites of enzymes which are involved 
in the enzyme's function. However modification of such amino- 
acids was difficult to detect and was achieved only by careful
Electron orH-atomTransfer >ensSubstrate 
(Type I ) (Type il )
substrate
Reactions of substrate Reactions of substrate
Figure Type I and II sensitized photooxidation jaechanisjas.
Vacant
orbitals Weaklyboundelectron
Filled
orbitals 4 — ^
hv
4- 4-44 4444 Oxidizinghole"
Groundstate Excitedsingletstate
Excitedtripletstate
Figure 1-7: Electronic energy states.
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selection of the dye and rigid reaction conditions; such 
experiments also involved the use of elaborately designed 
apparatus.
Brandt et al (1974) suggested that under certain 
experimental conditions the technique could be extended by using 
a dye or dye-ligand conjugate as a sensitizer with affinity for 
a protein binding site, thus favouring coupling to amino-acids 
in the binding site.
However an interesting proposal was put forward by 
Hemmendorff et al (1981) who developed a method for the covalent 
coupling of non-coloured low molecular weight substances to a 
protein upon excitation with visible light of a dye 
(fluorescein) in the presence of the protein and non-coloured 
substance. The coupling obtained was found to occur on solvent- 
exposed parts of proteins and was easily detectable since the 
low molecular weight label or tag used was tritiated tryptophan 
(C'^HItrp). This method of photosensitized radioactive surface 
labelling was selected for further development and assessment in 
these studies, and formed the basis of the rationale behind 
techniques used in this work.
Me.Qhaiilsms.
Fluorescein (molecular weight : 332) is a heterocyclic dye 
of the xanthene series which is insoluble in water, but soluble
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In dilute alkali. Fluorescein and related dyes are known to be 
efficient photosensitizers and this activity has been shown to 
be due to the light-induced conversion of the dye to a reactive 
species which represents the dye in the triplet state 
(Lindqvist, 1963; Kasche and Lindqvist, 1964;). It is the 
carbonyl group in fluorescein which has been shown to be 
photosensitive (see Figure 1-8).. Fluorescein may also react 
when in the excited singlet state but evidence suggests that the 
triplet state is responsible for the photoactivity of the dye, 
due to the longer lifetime of this state (Lindqvist, 1963). The 
generation of fluorescein molecules in the triplet state is thus 
a key factor in the reaction.
The excited molecules can then transfer the energy of this 
state to other molecules, thereby starting specific reactions.
If, as seen earlier, oxygen is present, triplet fluorescein 
reacts with oxygen and this results in the generation of the 
reactive species, singlet oxygen. The latter then continues the 
energy transfer process by photooxidising target molecules in 
solution.
( i ) Photosensi 11 zed... r.sidi.oag±iY@__la.b&ldiiig.
In the photosensitized radioactive labelling experiments 
carried out in this study, the reaction mixture was stirred 
using a magnetic stirrer, thus ensuring oxygen saturation and 
therefore the generation of the reactive singlet oxygen species. 
(For apparatus used, see Figure 2-6). The reaction solution
 ^ ^ photosensitiveO /carbonyl groupO
FLUORESCEIN
C00~ Na
protein
HYDROGENABSTRACTION
c=o
hV
C-0
OXYGENTRANSFER
protein
^ ] t r p
COVALENT BOND FORMATION
(a) PROTEIN -[HjTRP(b) PROTEIN - PROTEIN
Figure 1-8; Dye-sensitized radioactive photolabelling and cross-linking.
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conslsted of a mixture of protein, fluorescein, and radioactive 
tryptophan (see Figure 1-8). Singlet oxygen thus transfers its 
energy both to amino-acid residues on the polypeptide chains of 
the protein as well as to free ligands in solution, in this case 
C^HDtrp. The latter is thus converted to a free radical and 
reacts non-specifically with the protein surface. Covalent bonds 
are formed and the amount and position of binding of C"='H]trp can 
be investigated. This information will indicate which parts of 
the molecule are exposed to solvent and are therefore surface- 
orientated.
Covalent bonds formed, however, may be of two types (see 
Figure 1-8) namely (a), which is essentially the labelling 
reaction and (b), which consists of the protein cross-linking 
reaction. In the case of radioactive photolabelling reactions 
the latter is an unwanted side-reaction and conditions must be 
optimized so that (a) may be the predominant reaction occurring 
(see Chapter 3, Section 2). The degree of cross-linking is 
easily monitored by examining the irradiated protein on SDS-
polyacrylamide gels. |
II
(ii)F,hQ.t,Q.s.e.naitlzed .grQ.ss7lln3d..ag. !iAlthough the formation of stable protein cross-links is |
considered to be an unwanted side reaction in radioactive 
photolabelling, the potential of this reaction was realized and 
was developed as an independent means of investigation.
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The technique fallows similar chemistry to that of 
photosensitized radioactive labelling with one major difference, 
- no free [®H3trp is added to the system. Consequently the 
singlet oxygen acts as a cross-linking reagent, transferring its 
energy to protein molecules which form cross-links with any 
other protein (intermolecular cross-linking) or parts of the 
same protein (intramolecular cross-linking) which are in close 
proximity. Intermolecular cross-linking is favoured by higher 
protein concentrations and thus the resulting ratio of inter : 
intramolecular cross-linking can be controlled.
Because of the minute size of singlet oxygen, the 
possibility of reported reagent-induced conformational changes 
which result using classical cross-linking agents such as 
glutaraldehyde (Mossesson et al, 1981) and carbodiimide 
(Doolittle, 1984) are eliminated. Singlet oxygen also has 
additional advantages, - cross-links formed are not dependent on 
rigid spacing and specific target groups for the establishment 
of successful cross-links. The resulting cross-links are very 
short in length and thus cross-linked species must originally 
have been in very close proximity. This is not the case using 
chemical cross-linkers such as the bifunctional reagent dimethyl 
suberimidate which reacts specifically with lysine residues 
(Kennedy et al, 1976) to introduce cross-links 0.97nm is length, 
and tetranitromethane which reacts exclusively with tyrosine 
residues (Williams and Lowe, 1971). As well as this, in contrast 
with the vast majority of other cross-linking procedures, the
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reaction is not directed at lysine residues and therefore it is 
possible to carry out plasmin digestion on the cross-linked 
material and gain additional information regarding the 
topography of the protein in this way.
A similar type of experiment was carried out by Girotti et 
al (1979) who showed that extensive inter-subunit cross-linking 
resulted when a mixture of haemoglobin and methylene blue was 
exposed to light. The authors demonstrated that the rate of 
cross-linking was enhanced by DaO, indicating that singlet 
oxygen does indeed play a key role in the photooxidation 
reaction.
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Eart_...<3.1 : Aims..Qf...This Study
Despite all the research carried out on fibrinogen, certain 
basic aspects regarding, for example, the overall conformation 
of the molecule, remain unresolved. To date no single model 
proposed has been met with universal acceptance. In addition, 
the importance of calcium in influencing the structure and 
physiological properties of fibrinogen cannot be underestimated 
and remains the subject of much study and debate.
In this study two techniques have been selected for 
development and assessment, namely photosensitized radioactive 
surface labelling and photosensitized cross-linking. The main 
aim of this work was to develop the latter methods with a view 
to examining the conformation of fibrinogen (and its 
derivatives) in its native state and under different solvent 
conditions, with particular reference to the influence of 
calcium. The effects of other ions, such as magnesium and 
sodium, on the conformation of the protein were also 
Investigated.
C H A m S . T W Q
MATERIALS AKD METHODS
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S.e.cjLlg.n.. (A) : EEEFARAIIYE TECHNIQUES
1. The PurifioatlQn of Fibrinogen
Materials
- plasma (donated by the Blood Transfusion Centre, Minewell's 
Hospital, Dundee)
- lysine-Sepharose column (1 x 20cm) equlibrated in 0.05M 
Tris-HCl (Sigma), pH 7.5
- aluminium hydroxide gel (prepared by the method of Ikemori et 
al, 1975)
- saturated ammonium sulphate (BDH Analar)
- 23% saturated ammonium sulphate
- 'peak I' buffer, ie. 0.05M Tris-HCl, pH 8.6, containing 0.05M
FaCl and O.SmM CaCla
- DEAE-cellulose (Whatman DE52) column (2 x 25cm) equilibrated 
in peak I buffer
Method
Fibrinogen was purified from fresh frozen plasma and the
method used was based on that of Lawrie et al, (1979) (see
Figure 2-1),
Human Plasma
I------Plasminogen
Lysine-Sepharose column
Plasminogen-free plasma
Aluminium hydroxide gel
(------
Supernatant
Saturated ammonium sulphate
 1
Precipitate
(discard)
Precipitate
Wash in 23% saturated 
ammonium sulphate
Precipitate
Dialysis 
(2 hours/room temperature)
Suspension
DEAE-cellulose column
Read off peaks I - III
Supernatant
(discard)
Supernatant
(discard)
Figure 2-1; The Purification of Fibrinogen.
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The plasma was thawed in a constant temperature water bath 
at 37*C and any precipitate was removed by centrifugation (2,500 
rpm for 10 minutes). Plasminogen was removed from the plasma by 
passing the latter through a pre-equilibrated lysine-Sepharose 
column, as described by Deutsch and Mertz (1970). The eluate 
(ie. plasminogen-free plasma) was then brought to 37*C, a 1/10 
volume of aluminium hydroxide was added, and the mixture was 
stirred for 15 minutes. The aluminium hydroxide was subsequently 
removed by centrifugation (3,000 rpm for 10 minutes) and the 
resulting supernatant retained. The precipitate was then washed 
with a volume of pH 7.5 buffer equal to half the original plasma 
volume, and the centrifugation procedure was repeated. The 
resulting supernatant was added to that from the first spin and 
the aluminium hydroxide precipitate was discarded.
A 1/3 volume of saturated ammonium sulphate was added slowly 
to the combined supernatants and stirred for 10 minutes at room 
temperature. The mixture was centrifuged (3,000 rpm for 
10 minutes) and the supernatant discarded. After leaving the 
tubes to drain (upside down) for 10 minutes, the precipitate was 
washed with a volume of 23% saturated ammonium sulphate equal to 
one half the original volume of the combined supernatants, 
stirred for 10 minutes, and then centrifuged and drained as 
before.
The final precipitate was then resuspended in peak I buffer 
and dialysed against the said buffer (with buffer changes every
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20 minutes) for two hours at room temperature. The contents of 
the dialysis sac were subsequently brought to 37*C and any 
resulting precipitate was spun down using a bench centrifuge, 
prior to the sample being applied to the pre-equilibrated DEAE- 
cellulose column. It should be noted that the DEAE-cellulose was 
precycled prior to use, according to the manufacturer's 
Instructions.
The first protein peak (I) was eluted from the column with 
the peak I buffer. Two further peaks (II and III) were eluted 
with the same buffer first made O.IM and then IM in ïfaCl (see 
Table 2-i).
2. The. Eurlficatioa of. Plasminogen.
Materials..
- plasma
- lysine-Sepharose column (1 x 20cm) equilibrated in 0.05M 
Tris-HCl, pH 7.5
- 0.05M Tris-HCl, pH 7.5, containing 0.3M MaCl
- 0.IM EACA, pH 7.5
- 0.2M EACA, IM MaCl, pH 7.5
- ammonium sulphate
- 0, 05M ammonium bicarbonate
Table SzXl): Peak Analysis in the Purification of Fibrinogen.
BUFFER 
pH 8.6 ABSORBAMCE<280nm) FRACTION
0.05M Tris-HCl, 
O.SmM CaCla, 
0.05M MaCl. )0. 1 Peak I fibrinogen
0.05m: Tris-HCl, 
0.5mM CaCla, 
O.IM MaCl. >0.1 Peak II fibrinogen
0.05M Tris-HCl, 
O.SmM: CaClffi,
IM MaCl. Any third peak Fibronectin etc; (discard)
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Sephadex G-25 (Pharmacia) column (1.5 x 25cm) equilibrated in 
0.05M ammonium bicarbonate
Method
The first stage of this purification can be incorporated 
into that of fibrinogen (see Figure 2-1). The method used was 
based on those of Deutsch and Mertz (1970) and Rlckli and 
Cuendet (1971).
Plasminogen was absorbed onto a pre-equilibrated lysine- 
Sepharose column and the resulting plasminogen-free plasma was 
used for the purification of fibrinogen as seen earlier. The 
column was then washed overnight with the Tris/MaCl buffer, 
pH 7.5. This procedure was followed by the elution of various 
fractions off the column in EACA buffer, pH 7.5 (see Figure 
2-2). The EACA removes any plasminogen from the column by 
competing with lysine residues covalently bound to the 
Sepharose, to which the protein attaches. (The column may 
subsequently be cleaned after this stage with EACA/NaCl buffer, 
pH 7.5).
From the fractions collected, those with an Aaeo greater 
than 0.2 were pooled and 3.1g ammonium sulphate was added per 
10ml of pool. The mixture was stirred to dissolve the salt and 
then left at 4*C overnight. Any resulting precipitate was spun 
down using a bench centrifuge, and then dissolved in 
approximately 1ml ammonium bicarbonate. The sample was then
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applied to a pre-equilibrated Sepbadex G-25 column and of the 
fractions collected those with an Aaeo greater than 0.1 were 
pooled (see Figure 2-3). This pool was then divided into small 
aliquots (1ml) which were lyophilized and stored at -4*C until 
required.
3. El as2ni.ng.gie.n Act 1 vat i on
Materials
- 'plasminogen buffer', ie. 0.05M Tris-HCl, pH 7.4, containing 
0.012M NaCl
- streptokinase (Sigma) ; stock solution of 2,000 Units/ml 
Method
When required for the purpose of fibrinogen digestion, 
lyophilized plasminogen was resuspended in the above buffer. 
Streptokinase was then added to a final concentration of 10% 
(v/v) and the mixture was incubated at 37*0 for 15 minutes.
4. Elasminogen..and..Elasnin Assays
(1) FIasffli nogen 
Materials
As in 'Plasminogen Activation', plus : -
- 8-2251 (Kabi Diagnostica); stock solution : 1.7mg/ml
(oraog^) sou^qjrosqy
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Method
100^1 of streptokinase were mixed with an equal volume of 
plasminogen sample (resuspended in plasminogen buffer) in a 
cuvette. The mixture was then incubated at 37*C, in the heated 
cell carriage of a Cecil spectrophotometer, for 10 minutes.
700pl of plasminogen buffer (equilibrated at 37*0 were then 
added to the above, together with lOOjJil of the chromogenic 
substrate, 8-2251. The change in absorbance at 405nm was 
monitored using a chart recorder.
The enzymic activity was then calculated and expressed in 
arbitrary units of A Absorbance/minute/mg of protein, where one 
such unit = A of 0.01/minute; this is approximately
equivalent to 0.002 C.I., or Caseinolytic Units.
<ii> Elasmin 
Materials
- 'plasmin buffer* ie. 0.05M Tris-HCl, pH 7.4, containing 
0,. 112% HaCl
- 8-2251; Stock solution; 1.7 mg/ml 
Me.thQd.
800pl of plasmin buffer were added to lOOjil resuspended 
enzyme sample, all at 37*C. 100^1 of 8-2251 were then added to 
the mixture. The change in absorbance at 405nm was recorded, and 
the enzymic activity calculated as previously described.
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(iii) Examples.
In a typical experiment, two plasminogen samples, A and B, 
resulting from different purifications, were assayed. 8-2251 is 
a chromogenic substrate for both streptokinase-activated 
plasminogen (ie. plasminogen-8K> and plasmin. The principle of 
the reaction is as follows:-
8-2251 ie:-
H—D“Val—Leu—Lys-pNA  ---------------S>H—D—Val—Leu—Lys-OH + pITAenzyme
The method for the determination of activity is based on the 
difference in absorbance between the pNA (p-nitroaniline) formed 
and the original substrate. The rate of pMA formation, ie. the 
increase in absorbance at 405nm, is proportional to the enzymic 
activity and was determined using a spectrophotometer.
As can be seen from Figure 2-4, plasminogen A was found to 
be plasmin-free and therefore usable since this particular 
preparation will not tend to lose its activity by autolysis 
during storage. However, plasminogen B showed positive plasmin 
activity and was therefore discarded.
It should be noted that activity assays were routinely 
carried out on plasminogen preparations and rarely showed any 
plasmin activity. In fact, different plasminogen preparations 
showed very similar activities (ie. approximately 1,000
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'arbitrary' units) which were always sufficient to digest 
fibrinogen to its core fragments D and E,
5(i) Pr.eparati..Qn. of .Eragmeats D and E 
Materials
- fibrinogen (peak I or II)
- plasminogen
- streptokinase (stock solution; 2,000 Units/ml)
- DEAE-cellulose column (2 x 25cm) equilibrated in 0.05M 
Tris-HCl, pH 7.5, containing ImM CaCls
Method
The fibrinogen was dialysed overnight at 4'C, against five 
changes of the above pH 7.5 buffer. Plasminogen was then 
activated as described earlier and added to the dialyzed 
fibrinogen for digestion, using the relative quantities outlined 
by Lawrie et al (1977). The mixture was then incubated at 37*0 
for 4-6 hours and left at room temperature overnight. After the 
incubation period a digest sample was removed and run on an 
SDS-polyacrylamide gel (5% acrylamide) to check whether full 
digestion to the core fragments D and E had occured.
The digest mixture was then applied to the DEAE-cellulose 
column. After elution of one protein peak (ie. kz&o ) 0.1) the
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remaining protein was eluted using a NaCl gradient of 0 to 0.5M 
BaCI,
5(11) The. Digestion of Photolabelled or Cr-Pssrliaked Elbrlnogen
The full digestion of photolabelled or cross-linked 
fibrinogen was carried out in a similar manner to that 
previously described. However prior to digestion the samples 
were dialysed into 0.05M Tris-HCl, pH 7.5, containing O.IM BaCl 
and ImM CaCl%.
In the case of cross-linked samples the dialysis time was 
three hours, at room temperature, with buffer changes every 20 
minutes. This was done so as to remove any fluorescein present 
and also to prepare the samples in the appropriate buffer for 
digestion.
Vith respect to the photolabelled fibrinogen samples, the 
dialysis time was 48 hours, with approximately eight buffer 
changes. This extended dialysis time was required since not only 
was there need to remove any fluorescein present, but also the 
excess radioactive [^H]tryptophan label.
It should be noted that in the case of both cross-linked and 
photolabelled fibrinogen samples, separation of the core 
fragments simply by SDS-polyacrylamide gel electrophoresis (5% 
acrylamide) was adequate for the purposes of these experiments
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and separation by ion exchange chromotography on DEAE-cellulose 
was therefore not necessary,
6, Ihe Purification .of... Eluoresceln
Fluorescein (Fisons Scientific) was further purified by 
precipitation from a O.OIM UaOH solution by the addition of 
glacial acetic acid as described by Andersson et al (1971). The 
procedure was repeated three times, after which the molar 
absorption coefficient of the purified fluorescein in O.OIM NaOH 
was 8.4 X 10"* M"‘'cm"“’' at 491nm. A 3mM solution of fluorescein 
was prepared and stored in darkness at 4*C until required.
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Section (B). : AMLYIICAL. I£CHgIQU.ES.
1. Eolyacrylamlde ,.GsI. Electrophoresis 
Materials,
- Gel Buffer : 0.IK Tris-HCl, 6K urea (BDH),
0.2% Cw/v) SDS (BDH), pH 7.4 
(adjusted with HCl).
- Chamber buffer ; O.IM Tris-HCl, 0.2% (w/v) SDS, pH 7.4
- Acrylamide (BDH)/Bisacrylamide (BDH) stock solutions;
(i) 10% ; 9,7% (w/v) acrylamide
0.3% (w/v) bisacrylamide 
200ml gel buffer
(ii) 5% ; 4.7% (w/v) acrylamide
0.3% (w/v) bisacrylamide 
200ml gel buffer
- Ammonium persulphate (BDH) solutions:
150 mg/ml for the preparation of 3% gels 
120 mg/ml for 5% gels 
75 mg/ml for 10% gels
- TEMED (Sigma)
- Non-reducing medium : -8M urea
3% (w/v) SDS
Reducing medium
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8M urea 
3% (w/v) SDS
3% (v/v) p-mercaptoethanol (BDH)
- Bromophenol blue solution (0.05% w/v)
- Glycerol
- Indian ink
- Stain ! 3.3g Brilliant Blue R (Sigma: 75% purity)
454 ml methanol 
454 ml distilled water 
72 ml glacial acetic acid
- Destain : 250 ml methanol
675 ml distilled water 
75 ml glacial acetic acid
Ms.thod
In this work the procedure of polyacrylamide gel 
electrophoresis in the presence of sodium dodecyl sulphate 
(SDS-PAGE) was used to determine the molecular weight of 
proteins (Veber and Osborn, 1969), assess the purity of protein 
preparations, investigate the degree of enzymic degradation, and 
quantitate cross-linking reactions. The relevant protein bands 
on polyacrylamide gels were also cut out and solubilized in 
photolabelling experiments for estimation of radioactive 
incorporation.
:
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3% polyacrylamide gels were also used in these studies and 
the necessary acrylamide/bisacrylamide solution was prepared by 
dilution of the 10% stock solution. For preparation of the gels, 
19ml of the required acrylamide/bisacrylamide solution were 
mixed with the TEMED solution and the appropriate ammonium 
persulphate solution (freshly prepared), to the final 
concentrations given in Table 2-(ii). The latter was then mixed 
thoroughly and quickly pipetted into glass gel tubes 
(approximate dimensions ; 9.7 x 0.75 cm) which had been 
previously sealed at one end with parafilm. A gap of 1-1.5cm was 
left at the top of each tube and a few drops of distilled water 
were layered on top of each gel to prevent the formation of a 
meniscus. The gels were then left to set, a process taking 
approximately an hour, after which the distilled water was 
replaced by gel buffer. The gels were stored overnight at 4*C 
prior to use.
Normally 7-lOpg of protein was applied to each gel. Non­
reduced samples were mixed with an equal volume of non-reducing 
medium before application to the gels. Samples for reduction 
were mixed with an equal volume of reducing medium and boiled 
for five minutes.
All samples were then each mixed with approximately lOpl of 
bromophenol blue tracker dye and one drop of glycerol, and the 
whole volume was applied to the gel. (The bromophenol blue acts 
as a marker for the material's progress through the gel, whilst
Table 2-(il); Final Concentration of Components for SDS-Folyacrylamide 
Gel Polymerization.
ACRYLAMIDE/BISACRYLAMIDE 3% 5% 10%
Ammonium persulphate (w/v) 0. 075 0. 060 0,050
TEMED (v/v) 0. 150 0. 125 0.100
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the glycerol increases the density of the sample, thus reducing 
diffusion of the latter into the surrounding chamber buffer 
which is later layered over the samples).
The gels were then placed in a Shandon disc gel 
electrophoresis tank, chamber buffer was poured into each 
chamber (ie. upper and lower), and a current of approximately 
5mA per gel was applied, Electrophoresis was allowed to proceed 
until the marker dye was approximately 0.5-lcm from the bottom 
of the gel tube. The gels were then removed from the glass tubes 
by the injection of chamber buffer (by syringe) down the sides 
of the tube and the position of the marker dye on each gel was 
marked with indian ink.
The gels were then placed in stain solution for a minimum 
one hour period. After this procedure the gels were removed from 
the latter solution and placed in destain which was changed 3-4 
times over a 24-hour period,
After sufficient destaining, the gels were scanned using a 
Vitatron TLB 100 densitometer and, where necessary, the mobility 
of the protein bands was calculated using the following formula
Mobility = distance of protein migration
distance of tracker dye migration
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For each electrophoretic run, gels loaded with a mixture of 
reduced, standard proteins were included. The standards used 
were:
(a) myoglobin (MV : 17,000),
(b) soya bean trypsin inhibitor (MW ; 20,000),
<c) carbonic anhydrase <MV ; 29,000),
Cd) ovalbumin CMW : 45,000) and
<e) bovine serum albumin <M¥ : 116,000).
(All purchased from Sigma Chemical Co;).
By plotting the mobility of the standards against logio of their
known molecular weights, a calibration graph was obtained and
from this the molecular weights of unknown proteins was
estimated.
In cross-linking experiments the amount of cross-linking was 
quantified using scans of the gels obtained by 'Data Collect' 
and 'Data Anal' computer programmes. The Apple computer 
interface was directly linked to the Vitatron scanner 'record' 
output and the programmes used were adapted for compatibility 
with the densitometer by Dr. Graham Kemp.
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2. Laeaml i XDl sçont 1 nu Qua). Ge 1 s.
Materials.
- Acrylamide/bisacrylamide stock solution: 
30% (w/v) acrylamide
0.8% (w/v) bisacrylamide
- IM Tris-HCl, pH 6.8
- IM Tris-HCl, pH 8.8
- 0.2M EDTA-NaOH, pH 8.0
- 10% (w/v) SDS
- ammonium persulphate (10 mg/ml)
- TEMED
- Electrode buffer 0.025M Tris-HCl, 
0.192K glycine, 
0.1% (w/v) SDS, 
pH 8.3.
Stacking gel, layering buffer IM Tris-HCl, 
0.2M EDTA,
10% (w/v) SDS, 
pH 6.8.
Mathad.
The 'discontinuous' method of gel electrophoresis in 
acrylamide gels containing SDS was developed by Laemmli (1970)
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The percentage acrylamide combination of stacking:separating gel 
ratios used in these studies was 3;7&% and these gels were made 
up according to Table 2-(ill).
The separating gels (7%%) were prepared first and left to 
set for an hour in glass tubes (9.5 x 0,75 cm), previously 
sealed with parafilm at one end. During this period the gels 
were layered with a few drops of distilled water. The stacking 
gel solution (3%) was then prepared and pipetted on top of each 
of the separating gels, leaving a space of 1-1.5cm at the top of 
the tube. These gels were also layered with distilled water 
whilst setting. The length ratio between stacking and separating 
gels was approximately 1:10, usual lengths being approximately 
7.5cm for the separating gel and 0.75cm for the stacking gel. In 
order to facilitate pipetting, the glass tubes were previously 
marked on the outside (with a marker pen) at approximately 7.5cm 
and 8.3cm from the closed ends. After the stacking gels had set 
(approximately one hour) the distilled water layer was 
substituted with gel layering buffer and the gels were left 
overnight at 4*C prior to use.
Sample application onto Laemmli gels is the same as for SDS- 
PAGE and the Laemmli gels were also run according to the latter 
procedure. Differences between the two techniques lie in the 
fact that Laemmli gels are run at the reduced current of 3mA per 
gel and the buffer used in the Shandon tank chambers is of a
Table Final Concentration of Components Required for the
Polymerization of 3% Stacking Gels and 7%% Separating Gels.
SOLUTION STACKING GEL SEPARATING GEL
Acrylamide:bis 3% 7%%
Tris-HCl, pH 6.8 0.065M --
Tris-HCl, pH 8.8 -- 0.375M
EDTA, pH 8.0 0.002M 0.002M
10% (w/v) SDS 0. 1% 0. 1%
Ammonium persulphate 0. 1% 0. 05%
TEMED 0. 1% 0. 05%
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different composition and pH to the chamber buffer previously 
used in the SDS-PAGE method.
3. PetectlQB. of Protein
The presence of protein in solution was usually determined 
by measuring the absorbance of solutions at 280nm. The Ei% 
(absorption coefficient) of the proteins used in this work (at 
280nm) are known (Harder et al, 1969) and are shown in Table 
2-(iv).
When the concentration of the samples was too low to 
determine the concentration of the protein accurately using the 
above method, protein estimations were carried out using the 
method of Bradford (1976). The latter method was also used in 
all cases where fluorescein had been added to the system. All 
measurements using the Bradford method were carried out in 
duplicate.
Table 2-(iv); Ei% Values (280nm) of Some Proteins Used in This Study.
PROTEIN ABSORPTION COEFFICIENT 
(<Ei%> at 280nm)
Fibrinogen 15.1
Fragment X 14.2
Fragment D 20.8
Fragment E 10.2
Plasminogen 17.0
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Section (C): EXPERIMENTAL TECHNIQUES
1. EhQt.osen.sltlzed ..£a.dlaact 1 Y2_la.beili.ng
The technique used was based on that of Hemmendorff et al 
(1981). An outline of the experimental protocol can be seen in 
Figure 2-5. However various problems were encountered at certain 
stages and a detailed account of how these were tackled and 
overcome can be seen in Chapter 3, Section 2 (Development and 
Optimization of Techniques).
The protein to be photolabelled was first dialysed into the 
appropriate buffer. 0.9ml of protein (0.3 - 0.6 mg/ml) were then 
mixed with 0.5ml 3mM fluorescein (purified as previously 
described) and 0.1ml of a 0.05mM radioactive tryptophan mix. (It 
should be noted that the latter represents a mixture of 
L-CG-:^H]-tryptophan (Amersham International, pic) diluted with 
'cold' L-tryptophan (BDH) to give a constant specific activity 
of 3.374 pCi/nmole). The apparatus used in a typical irradiation 
experiment can be seen in Figure 2-6. The mixture was stirred 
(thus ensuring that the solution was oxygen-saturated) in a 
sample vial (diameter : 2cm) which was placed in an ice bath at 
a constant distance of 13.5cm from the light source. The 
reaction mixture was then irradiated for a set period of time 
with a 500 or 1,000 Watt Philips lamp. After irradiation, 
fluorescein and excess tryptophan were removed from the sample 
(see Chapter 3, Section 2) and labelled proteins were seperated
Purification of Protein (eg; fibrinogen)
Dialysis Into Appropriate Buffer
Photosensitized Radioactive 
Labelling
Removal of excess C ®H]tryptophan
Protein Estimation 
(Bradford Test)
SDS~polyacrylamide gel 
electrophoresis
Scan gels and photograph
Cut out protein bands 
and solubilize
Calculate radioactive 
incorporation
Photosensitized
Cross-Linking
SDS-polyacrylamide gel 
electrophoresis
Scan gels and photograph
Figure 2-5 : Experimental Protocol.
IRRADIATION
SOURCE
/
MAGNETIC STIRRER
13 " 5 cm
ICE BATH
REACTION VESSEL
2~^: Apparatus used for sample irradiation.
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by SDS-PAGE. Whenever necessary the gels were scanned using a 
Vitatron TLD 100 densitometer.
Stained bands were cut out of the gel using either a 'blade 
cutter' (1mm slices) or a scalpel. The gel slices were then 
solubilized in 0,5ml of 30% (w/w) hydrogen peroxide (BDH) in 
sealed vials at 75*C for eight hours, on a constant temperature 
heating block (Grant). After solubilization and cooling of the 
vials to room temperature, 4ml of toluene scintillant (prepared 
as described by Cooper, 1977) were added to each vial and the 
contents were mixed thoroughly using a vortex mixer. The amount 
of radioactivity in each vial was then measured in triplicate 
using a Packard Tri-Carb 300 CD scintillation counter.
In addition to the stained protein bands, the rest of the 
gel was also cut up and solubilized. The average of the 
radioactivity measurements from such portions of the gel were 
subtracted as background values from the radioactivity 
measurements of the protein-containing vials.
2. PhotQaeasitized Cross-Linking
As with photosensitized radioactive labelling, a description 
of the optimum conditions for this technique is given in Chapter
3, Section 2; however a rough outline of the experimental 
protocol can be seen in Figure 2-5. The technique of 
fluorescein-activated cross-linking follows similar chemistry
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and uses similar apparatus (Figure 2-6) to that of 
photosensitized radioactive labelling with one major difference, 
- no tryptophan is added to the system.
Thus 1ml of protein (0.7 mg/ml) in the appropriate buffer 
was mixed with 0.5ml of 3mH fluorescein. The irradiation 
procedure was carried out as previously described and cross- 
linked products were subsequently analysed by SDS-PAGE and/or 
Laemmli gels. The gels were then scanned using a Vitatron TLD 
100 densitometer and the calculated peak areas were used to 
determine the relative amounts of protein present.
CHAmR.THREE.
RESULTS.
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Section (l)i Purifications
Elbr.iiL.Qgen.
Fibrinogen was purified from human plasma by a method 
adapted from that of Lawrie et al (1979), as outlined in the 
previous chapter. The primary objective was to obtain a good 
yield of high quality fibrinogen, having as intact an Aa-chain 
as possible.
Figure 3-1 shows the elution profile of the DEAE-cellulose 
column used in the final stage of the purification. Peak I 
characteristically contains the most intact fibrinogen and peak 
II a somewhat less intact fibrinogen type. This difference can 
be seen in Figure 3-2 where discontinuous Laemmli gels (3:7%%), 
which have a higher band resolution than SDS-polyacrylamide 
gels, were run in order to highlight such differences. The 
Aa-chain band of reduced peak I fibrinogen is more Intact than 
that of the peak II gel, in which the Aa-chain has been 
partially degraded. According to the work of Mosesson et al 
(1974) and Semeraro et al (1977), this is the result of the 
digestion of the labile C-termlnal parts of the Aa-chains which 
gives rise to the heterogeneity of these chains.
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The graph in Figure 3-1 represents a satisfactory 
preparation in which a high yield of good quality peak I
%fibrinogen resulted. Figure 3-3 shows the appearance of peak I
•2fibrinogen, both reduced and non-reduced. on 5% and 3% SDS- 
polyacrylamide gels respectively. The decreased band resolution , ^
for the reduced 5% SDS gels as compared to the Laemmli gels 
(Figure 3-2) should be noted.
Eragments-.D- .aad E
The digestion of fibrinogen by plasmin was carried out by 
the method described in the last chapter. This was done in the 
presence of calcium (ImM) since, as seen earlier, Haverkate and 
Timan (1977) showed that D(cate) (ie. the final fragment D 
product resulting when calcium is present) is protected from 
further plasmin attack by calcium ions. (IT.B. From here on this 
fragment will simply be referred to as fragment D).
Figure 3-4 shows a 5% SDS-polyacrylamide gel of the 
digestion mixture, where the digestion resulted in the core 
fragments D and E. The mixture was then applied to a precycled 
DEAE-cellulose column, the elution profile of which can be seen 
in Figure 3-5. After elution of one protein peak in 0.05M Tris- 
HCl, pH7.5, containing ImM CaCla, the remaining protein was 
eluted using a sodium chloride gradient of 0 to 0.5M NaCl-.
e0
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B0 7
e ©
5% acrylamide 3% acrylamide
Figure 3-3: SDS-polyacrylamide gels of reduced (5% acrylamide) 
and non-reduced (3% acrylamide) fibrinogen.
0Fragment D 
Fragment E
©
Figure 3-4: The digestion of fibrinogen to fragmente D and E. 
(Photograph of 5% acrylamide gel).
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Peak (i) was found to consist of fragment D having an 
apparent molecular weight (calculated from SDS-polyacrylamide 
gels) of 07,000, whilst peak (iii) consisted of fragment E with 
an apparent molecular weight of 50,000. Gels of peak <ii) showed 
a mixture of the two protein species.
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Section (2): Development and Optimization of Techniques,
As seen previously, the primary objective of this work was 
to develop two techniques, namely photosensitized radioactive 
labelling and photosensitized cross-linking, with the aim of 
applying these methods to investigate the topography of 
fibrinogen. In very simple terms, photosensitized labelling 
indicates how much of the molecule is surface-orientated whilst 
cross-linking indicates which parts of the molecule are closest 
together.
Both techniques have three main advantages in common, 
namely:
(i) All experiments are carried out in solution; thus fibrinogen 
is labelled or cross-linked in its native state and no rigorous 
conditions are required for these techniques.
<ii) The initiation and duration of the reaction can be easily 
controlled and,
(iii) both processes occur via highly reactive, short-lived 
intermediates.
Conditions for both techniques had to be optimized, hence a 
great deal of the initial work was concerned with experimental 
design.
A rough outline of the experimental protocol can be seen in 
Figure 2-5 (Chapter Two). Various problems were encountered at
-56-
the different stages and the following section deals with how 
the latter were tackled and overcome.
Light. Source.,.
Initial photosensitized radioactive labelling experiments of 
fibrinogen, in 0.05M Tris-HCl, pH 7.5, containing 2inM CaCl%, 
(from here on referred to as the Tris/CaCl# buffer) were carried 
out using a 500 Watt lamp (Philips) and the resulting degree of 
incorporation was found to be insufficient for subsequent 
analysis. However, when this was changed to a 1,000 Watt lamp 
(Philips Vatastar 1000), the amount of radioactive incorporation 
increased by approximately 13 times. This result can be seen in 
Table 3-(i) where time of irradiation is 60 seconds. The light 
intensity generated by either of the two lamps was measured 
using a Macam Quantum Photometer (model number: QlOl-1) for a 
distance of 13.5cm. It was found that the intensity of the 500 
Watt lamp is 1,090 pMoles m"^s"'' whilst that of the 1, 000 Watt 
lamp is 9,007 pmoles m“^s“\  approximately eight times as much. 
Thus, as their name implies, photosensitized reactions are 
primarily dependent on the intensity of the light source used.
Although the effect is accompanied by an increase in protein 
cross-linking, which in this case is an unwanted side reaction, 
as will be seen in later experiments, conditions were optimized 
so that the latter reaction was decreased to an acceptable 
level. In photosensitized radioactive labelling, the main
Table 3-(l); Dependence of Radioactive Incorporation on Light Source 
Used.
LIGHT SOURCE"" INCORPORATION(Watts) (dpm/pmole fibrinogen)
500 52. 0
1000 696.6
The above results represent the mean of five experiments. 
In all cases the standard error was < ± 9%
* Irradiation time = 60 seconds
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objective is that "P-[ trp" should be the predominant end- 
product where P = protein and [^Hltrp = tritiated tryptophan.
This can be done, for example, by selecting a shorter 
irradiation time which in turn also decreases the possibility of 
any adverse effects occuring, such as dénaturation of the 
protein by heat. The temperature of the reaction mixture was 
measured after 30 seconds and 60 seconds exposure by the 1000 
Watt lamp. The highest temperatures recorded after the latter 
irradiation times were 19*C and 32*C respectively, where the 
initial temperature prior to illumination was 10*C in both 
cases. As will be seen in this chapter, a fixed irradiation time 
no longer than 30 seconds was selected for all future 
experiments.
Another option is to minimize the concentration of protein 
used, bearing in mind that it is necessary to have sufficient 
protein present for: (a) subsequent analysis on SDS-
polyacrylamide, or Laemmli, gels after labelling, and
(b) digestion of the labelled fibrinogen, Consequently, unless 
specified, the concentration of protein used in each 
photolabelling experiment was 1.32nM <0.3mg/ml).
Initial attempts to cross-link fibrinogen in the Tris/CaCls 
buffer (pH = 7,5), using a 500 Watt lamp also proved to be 
futile, even though experimental conditions such as the 
following (overleaf) were varied:
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(a) time of irradiation (from 25-90 seconds),
(b) protein concentration (from 2-6 nM),
(c) fibrinogen derived from various purifications,
(d) distance of light source from sample,
(e) fluorescein prepared from different batches.
The only suggestion that cross-linking had occured resulted 
when 20pl of the free radical catalyst accelerator, TEMED, were 
added to the sample immediately prior to irradiation. This 
generated some fibrinogen dimer and a very small amount of the 
trimer species, as observed on 3% SDS-polyacrylamide gels. On 
examination of the reduced protein on Laemmli gels (3:7%%), some 
high molecular weight cross-linked bands were observed, situated 
above the Aa band. However, when a Philips Vatastar 1000 lamp 
was used, the evidence that cross-linking had occurred became 
very clear as will be seen in all future experiments. The final 
concentration of protein used in each photosensitized cross- 
linking experiment was 2.94nM (0.67mg/ml).
Removal of Fluorescein and Excess C "'H]tryptophan Following the 
Eh&taiabelliBg React i on.,.
Cross-linked samples could be run directly on gels without 
prior removal of the heterocyclic dye, fluorescein (molecular 
weight, 332). Due to its comparatively low molecular weight, the 
latter is removed from the protein sample simply by the 
electrophoretic technique itself. However a different situation 
presented itself in photolabelling reactions since it was found
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that excess, unbound, radioactive [^H]tryptophan could not be 
removed simply by gel electrophoresis. Two possibilities for the 
removal of excess label after the reaction was carried out were 
investigated, These were;
(1) dialysis, or,
(ii> gel filtration using a Sephadex G-25 column.
As mentioned previously, it is more advantageous to use a 
low protein concentration in photolabelling experiments so that 
minimal cross-linking occurs. However, in the initial pilot 
experiments a final concentration of 0.42mg/ml <l,85nM) 
fibrinogen was labelled per irradiation experiment.
In gel filtration, the labelled protein was recovered in the 
various fractions eluting off the Sephadex G-25 column.
Following the simultaneous application of five photolabelled 
fibrinogen samples onto the column, a maximum yield of 0.13mg/ml 
was recorded in the peak protein fraction. Such recovery 
concentration meant that the fraction had to be freeze-dried in 
order to run gels. In view of the lability of the Aa-chains and 
low protein recovery following freeze-drying, a method where 
this step is not necessary was preferable.
With dialysis, a concentration of approximately 0.3mg/ml 
protein per sample dialysed was recovered. Thus no freeze-drying 
was necessary and gels could be run directly after dialysis. 
Figure 3-6 shows two gels (5% acrylamide) of reduced pre- and
I ■
i H
Pre-dialyeis Post-dialysis
Figure j-f; SDS-polyacrylamide gels (5% acrylamide) of reduced 
fibrinogen before and after dialysis.
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post-dialysis fibrinogen which had been dialysed for 24 hours at 
4*C. As can be seen from these gels, the integrity of all bands 
has been preserved,
A study to investigate the efficacy of dialysis in the 
removal of unbound C t r y p t o p h a n  was also carried out. The 
radioactive photosensitized labelling procedure was carried out 
as described in the previous chapter, on a sample containing no 
protein (irradiation time = 60 seconds). The radioactive mixture 
was then dialysed for 24 hours at 4 ’C. Samples were removed 
prior to dialysis and also 3 hours, 17 hours and 24 hours after 
dialysis had been initiated. The radioactivity contained in a 
1:100 dilution of each sample was then measured (dpm) and the 
results can be seen in Table 3-(ii), under the heading "BLANK”.
As can be seen from this Table, dialysis is an efficient way 
of removing unbound radioactivity; even though this method does 
not remove 100% of the initial radioactivity, it is 99.7% 
effective. The residual radioactivity, although minimal compared 
to pre-dialysis levels, may be due to adherence of the 
[^H]tryptophan to the dialysis sac.
The experiment was then repeated under the same conditions 
however this time the sample contained fibrinogen (concentration 
= 0.31mg/ml). After 24 hours, it was found that a higher level 
of residual radioactivity resulted, compared to the blank 
experiment, indicating that [#H]tryptophan must have bound to
Table 3-(ll); The Removal of Excess C®H3tryptophan By Dialysis.
BLANK + PROTEIN
Sample Radioactivity (dpm) Radioactivity (dpm)
predialysis 115,630 114,027
+ 3 hours 1,885 -
+ 17 hours 593 "
+ 24 hours 450 2,844
The above results represent the mean of three experiments. 
In all cases the standard error was < ± 3.5%
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the protein. It should be noted, however, that since not all of 
the unbound radioactivity is removed by dialysis, calculations 
regarding the actual amount of radioactive label binding to the 
protein must be based on data derived from the solubilization of 
radioactive gels and not simply from post-dialysis readings of 
protein solutions,
Ircadiatlon Time
Initial radioactive photosensitized labelling experiments on 
fibrinogen were carried out for irradiation times of 60 seconds 
and 30 seconds according to the method described in the previous 
chapter, in the Tris/CaCla buffer, (pH =7.5), at a final 
protein concentration of 1.85nM.
Fibrinogen samples from each of the irradiation times were 
then run on 3% SDS-polyacrylamide gels; examples of densitometer 
scans can be seen in Figures 3-7 (a) and (b). As can be seen 
from the latter, the proportion of fibrinogen dimer and trimer 
is greater at 60 seconds than at 30 seconds. A small proportion 
of tetramer is also present at 60 seconds (this can also be seen 
in Table 3 (iii)). The incorporation (dpm per pmole fibrinogen) 
was measured by solubilization of the radioactive gels run and 
it was found that the incorporation at 30 seconds was 
approximately half that resulting from a 60 second irradiation 
time. The total amount of polymer at 30 seconds (15.8%) is also 
approximately half that obtained at 60 seconds (31,2%); however
M-
Eigur.e...2z:Z<a^  : Densitometer scan of an SDS-polyacrylamide gel
(3% acrylamide) for a fibrinogen sample irradiated 
for 30 seconds.
M  = monomer 
D = dimer 
T - trimer
MEjgUTjB.. 3-7 <b? : Densitometer scan of an SDS-polyacrylamide gel
(3% acrylamide) for a fibrinogen sample Irradiated 
for 60 seconds.
M  = monojmr 
D - dimer 
T = trimer 
Q = tetramer
Table 3 % (iii): Photosensitized Radioactive Labelling àt 30 seconds and 60 seconds.
(Buffer used: 0.05% Tris-HCl, 2m% CaCla, pH = 7.5)
IRRADIATION
TIME
(seconds)
%%ONOMER %DIMER %TRIMER %TETRAMER %INCORPORATION
(dpm/pmole
fibrinogen)
30 84.2 12.9 2.9 - 297. 0
60 68.8 22.2 7.2 1.8 696.6
The above results represent the mean of five experiments. 
In all cases the standard error was ( ± 7%.
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the possibility of decreasing the irradiation time further so as 
to minimize cross-linking was investigated.
Consequently the aim of the next experiment was to 
investigate incorporation and cross-linking patterns of 
fibrinogen at various times of Irradiation namely 10, 20, 30,
45, and 60 seconds. From the latter, a suitable irradiation time 
for future experiments was selected.
A graph of residual radioactivity in the dialysed samples 
(following irradiation) versus irradiation time can be seen in 
Figure 3-8, This demonstrates that the longer the irradiation 
time, the greater the amount of radioactivity present in the 
dialysate and thus bound to the protein.
3% SDS-polyacrylamide gels were then run for the non­
reduced fibrinogen samples (see Figure 3-9). As time of 
irradiation is increased, the appearance of dimers, trimers and 
even tetramers (at 60 seconds) of fibrinogen result due to 
intermolecular cross-linking. Figure 3-10 shows two graphs of 
% fibrinogen monomer/polymer versus irradiation time (seconds) 
which are the result of scanning the 3% gels using a 
densitometer. The graphs show that a decrease in the amount of 
fibrinogen monomer with time is coupled by a proportional 
increase in the amount of polymer present. From such graphs it 
was concluded that irradiation times above 30 seconds can be 
discarded since the amount of cross-linking which results is too
01
10 20 30 40 50 60
Irradiation tijob (seconds)
Figure 3-3: Graph of residual radioactivity in dialysed samples 
(dpm X 10“^) versus irradiation time (seconds).
The points represent the mean of two experiments.
10 20 30 45 60
Time (seconds)
M  = monomer 
D = dimer 
T = trimer 
Q = tetramer
ElgUTQ 3.t9: SDS-polyacrylamide gels (3% acrylamide) of fibrinogen
irradiated for 10 - 60 seconds in 0, 05M Tris-HCl, pH 7.5, 
containing 2mM CaClj;.
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high, In fact, an irradiation time of 20 seconds, to be used in 
all future photosensitized labelling experiments was selected at 
this stage. This irradiation time represents the best 
compromise, where the degree of cross-linking is comparatively 
small and the level of incorporation is sufficiently high for 
analysis. Also on the basis of these results, an irradiation 
time of 30 seconds was selected to be used in all 
photosensitized cross-linking experiments.
It is also interesting to note that if the graphs are 
extrapolated back to time t = 0, the initial amount of monomer 
present (under these experimental conditions) is approximately 
91.5%, whilst the amount of polymer present is 8.5%. This 
suggests that some of the fibrinogen is already present as 
polymer in its native state. The latter complexes would not be 
detected on SDS-polyacrylamide gels due to the SDS/urea in the 
gel system which would break down any such intermolecular bonds 
present.
The radioactivity of the gel slices was then measured after 
solubilization and the incorporation patterns were noted and 
compared for various irradiation times. From Figure 3-11 it can 
be seen that:
Incorporation a Irradiation time.
It should also be noted (from this graph) that the degree of 
radioactive Incorporation for the selected irradiation time of 
20 seconds is sufficient for analysis.
0
%
q1q
g
<UI
30 5010 20 40 60
Irradiation time (seconds)
Figure 3-11: Graph of radioactive incorporation (dpm/pmole fibrinogen 
X versus irradiation time (seconds).
(Buffer; 0.05K Tris-HCl, pH 7,5, containing 2mM CaCl:.^ ). 
The points represent the mean of two experiments.
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Section <3): Buffer., Effec..t.a
There has been much controversy concerning the conformation 
of fibrinogen with several models being put forward ranging from 
a trinodular structure (Hall and Slayter, 1959) to a more 
globular model (Koppel, 1966).
Although there are a number of possible reasons for the 
plethora of models, such as different methods of fibrinogen 
preparation or artefacts of the techniques used to examine 
conformation, an attractive proposition is that of Mueller and 
Burchard (1978). These authors suggest that fibrinogen is a 
flexible molecule dependent on the particular enviroment.
Thus, once the main problems in the experimental methodology 
had been overcome, the next step was to test the above premise 
by investigating the photosensitized labelling and cross-linking 
of both fibrinogen and its plasmin derivatives, fragments D and 
E, under different conditions, with particular reference to the 
influence of calcium.
(i) - The aim of the first experiment was to investigate the 
effect a buffer of different composition and pH to the one used 
previously (i.e. 0.05M Tris-HCl, pH 7.5, containing 2mM CaCla) 
would have on the incorporation and cross-linking patterns of 
fibrinogen at various irradiation times. The last experiment in 
Section (2) was thus repeated, however in this case the selected
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buffer was 0. 13M TTaCl, 6,7mM sodium phosphate, pH 7,0 (from here 
on referred to as the NaCl/phosphate buffer), This particular 
buffer was chosen since, apart from being completely different 
in composition and pH to the initial buffer used, it contains no 
added calcium and is also the buffer used by Hemmendorff et al 
(1981), on whose photosensitized labelling technique this method 
is based.
It should be noted that although the NaCl/phosphate buffer 
contains no added calcium, no rigorous attempts were made to 
remove calcium from the fibrinogen. In fact, atomic absorption
measurements for the calcium content of such 'calcium-free' ji
buffers showed that these do indeed contain traces of calcium 
ions (Boss, 1982), example:
(i) 0.05M Tris, pH 7.5 : contains l.QOpM Ca'*"'"
(ii) 0.15M NaCl : contains 3.75pM Ca""'*"
(iii) 0. 05M Tris, 0.15M NaCl, pH 7.5 : contains 5.00pM Ca""'
Thus the calcium high affinity sites can assumed to be occupied
at "zero" calcium concentrations used in these and following 
experiments.
After irradiation and dialysis, 3% and 5% SDS-polyacrylamide 
gels were run for non-reduced and reduced fibrinogen samples 
respectively. (See Figures 3-12 (a) and (b)>. Although, as can 
be seen from the 3% gels, there is an increase in the amount of 
polymer formed with irradiation time, this increase is not as 
marked as it was in the Tris/CaCls buffer. The appearance of
rrt.
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I ■
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Pijl
60
Time (seconds)
Figure 2-.12{n): SDS-polyacrylamide gels (3% acrylamide) of fibrinogen 
irradiated for 0 - 6 0  seconds in 0.13H NaCl,
6.7mM sodium phosphate, pH 7.0,
I
0 30
m
ï:';|
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Figure dzl2(b): SDS-polyacrylamide gels (5% acrylamide) of fibrinogen 
irradiated for 0 - 6 0  seconds in 0.13M NaCl,
6.7 mM sodium phosphate, pH 7.0, then reduced.
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trimer is only just apparent at 30 seconds and no tetramer is 
present at 60 seconds. This contrasts with the results in the 
previous section where appearance of trimer, albeit minimal, 
occurs at 20 seconds and where tetramer is clearly seen on the 
60 second gel. These results suggest that fibrinogen is a 
molecule whose conformation is influenced by its enviroment. It 
is also possible that the increased amount of intermolecular 
cross-linking seen in the Tris/CaCl% buffer could be due to the 
molecule adopting a more open conformation under these 
conditions.
The radioactivity of the gel slices was then measured after 
solubilization and the incorporation plotted for the various 
irradiation times (see Figure 3-13). The relationship between 
these two variables is still linear, however it should be noted 
that the overall level of Incorporation into fibrinogen, as 
measured in the two buffers, is different; this is significantly 
higher in the NaCl/phosphate buffer.
(ii) - The next step was to investigate the photosensitized 
labelling of a derivative molecule of fibrinogen, namely the 
plasmin-derived core fragment E, in the two different buffers 
(irradiation time = 20 seconds, concentration = 1.85nM).
The non-reduced, labelled, fragment E was run on 5% SDS- 
polyacrylamide gels and the protein bands solubilized. The 
incorporation resulting in the two buffers can be seen in
»<
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Irradiation time (seconds)
Figure Graph of radioactive incorporation (dpa/pmole fibrinogen
X 10~^) versus irradiation time (seconds),
(Buffer: 0.13K NaCl, 6.7mK sodium phosphate, pH 7.0),
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Table 3-(iv). Incorporation levels in the KaCl/phosphate buffer 
are approximately four times those found in the Tris/CaCla 
buffer.
Four possibilities as to why this should happen were 
investigated;-
(a) - the photolabelling reaction proceeds via free radical 
intermediates; the depressed incorporation in the Tris/CaCla 
buffer could be attributed to a possible free radical scavenger 
effect of Tris,
<b) - the pH of the buffer affects the protein's conformation 
and thus incorporation levels,
(c) - the pH of the buffer affects the rate of the reaction, or 
<d) - the conformation of the protein is influenced by calcium 
which is only present in one of the buffers.
(ill) - In order to investigate whether Tris has an inhibitory 
effect on the labelling reaction and consequent radioactive 
incorporation, fragment E was labelled in the two different 
buffers used previously, but this time made up to the same pH, 
i.e. pH 7.5 (This was done to eliminate any pH effects). The 
resulting incorporation into fragment E can be seen in Table 
3-(v).
Even though the pH of both buffers is 7,5, incorporation in 
the Tris/CaCla buffer is still much lower, These results suggest 
that the presence of Tris is a factor contributing towards this
Table 3-(lv>; Incorporation of Radioactive Label Into Fragment E.
BUFFER INCORPORATION 
(dpm/pmole Fragment E>
0. 05H Tris-HCl, 
2mM CaCl=, 
pH = 7.5
65. 0
0. 13M NaCl,
6.7mM sodium phosphate, 
pH = 7.0
281.7
The above results represent the mean of six experiments.
In all cases the standard error was < ±6%, and the significant 
difference, p, was ( 0.001,
IaM.e,.„.3r,.<v) : Incorporation of Radioactive Label Into Fragment E at pH 7.5.
BUFFER INCORPORATION 
(dpm/pmole Fragment E)
0.05M Tris-HCl, 
2mM CaClz, 
pH = 7.5 65. 0
0.13M NaCl,
6.7mM sodium phosphate, 
pH = 7.5 187.9
The above results represent the mean of six experiments.
In all cases the standard error was < ± 6.5%, and the significant difference, p, was  ^ 0.001.
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decreased level of incorporation by its action as a free radical 
scavenger. In fact this was also seen later, from results of 
cross-linking experiments done in the two buffers. However, it 
should be noted that Tris may simply be one of several factors 
contributing to this difference since the buffers under 
comparison are different in several other respects, as well as 
the Tris content.
It was also noted that the incorporation into fragment E was 
different for the two identical NaCl/phosphate buffers made up 
at different pH's (see Tables 3-(iv) and 3-(v)). Thus, the next 
experiment was designed to answer the following question:- Does 
the pH of the buffer affect the incorporation of radioactivity 
into fragment E by altering the rate of the reaction, or the 
conformation of the molecule?
(iv) - 8M urea was used to eliminate differences in protein 
structure at the different pH's due to its denaturing effect on 
the molecule. Thus, radioactive incorporation should be the same 
for each pH unless the reaction is pH-sensitive in which case 
incorporation at the various pH's will differ.
The buffer used was 0.13M NaCl, 6,7mM sodium phosphate, 8M 
urea, made up at pH = 7.0, 7.5 and 8.0 respectively. The results 
can be seen in Table 3-(vi) and Figure 3-14, where the latter 
represents the radioactivity profile along each of the three 
gels representing the different pH's.
Table 3-(vi); Radioactive Incorporation Into Fragment E at pH 7.0, 7.5, 
and 8,0, in 8M Urea.
Buffer used : 0.13 M NaCl,
6.7mM sodium phosphate, 
8M Urea.
pH INCORPORATION 
(dpm/pmole fragment E)
7. 0 22.6
7.5 63.4
8. 0 131.5
The above results represent the mean of two experiments.
In all cases the standard error was < ± 12%, and the significant 
difference, p, was < 0.05.
20
0 
%1 ~ pH 6. 0^ pH 7,5
= pH 7.0
15
10
2 4
Distance (cjas)
Figure 2-14/ Graph of radioactive incorporation (dpm x 10~^) versus 
distance from top of gel (oms).
(Gel acrylamide concentration - 5%).
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The results clearly indicate that the rate of the reaction 
is dependent on pH. It is therefore important to select and work 
at one specific pH so as to eliminate such effects. The pH 
chosen for the rest of the experiments was pH 7.5.
The results also show and confirm that the photosensitized 
labelling technique is indeed conformation-dependent. This is so 
since the level of incorporation into fragment E, at pH 7.0 and 
pH 7.5 respectively, is different to that which resulted when 
the same experiment was repeated in the presence of 8M urea 
(compare results in Tables 3-(iv) and 3(v> with those in Table 
3(vi)>.
Cv) - The final photosensitized labelling experiment in this 
section was carried out on fibrinogen in three buffer systems, 
namely : -
(A) 0.13 K UaCl, 6.7mM sodium phosphate, pH 7.5,
(B) 0.05M Tris-HCl, pH 7.5, and
(C> 0.05M Tris-HCl, 2mM CaCla, pH 7.5.
The aim of this experiment was to investigate whether the 
protein's conformation is directly influenced by the presence of 
calcium. Thus buffer <B>, (from here on referred to as the Tris 
buffer), was used for direct comparison with the calcium- 
containing buffer (C).
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Intact fibrinogen was labelled for 20 seconds and the 
incorporation of surface label onto the protein and its 
constituent chains was measured. The results for non-reduced 
fibrinogen are shown in Table 3-<vii) whereas those for the 
reduced chains can be seen in Table 3-<viii).
Table 3-<vii) illustrates once again that less overall 
incorporation occurs in both Tris-containing buffers compared to 
the NaCl/phosphate buffer. However, there is a difference in 
incorporation between the two Tris-containing buffers, where a 
higher level of incorporation occurs in the Tris/CaCl^ buffer.
The results presented in Table 3-<viii) show that the 
distribution of label incorporated into the three constituent 
chains of fibrinogen is similar in ratio for buffers (A) and
(B), but not for buffer (C). This suggests that conformational 
change is a factor contributing towards the difference in 
incorporation. In the Tris/CaCla buffer the Aa-chain takes up 
almost as much label as the other two chains combined, whilst in 
both the Tris and NaCl/phosphate buffers the Aa and %-chains are 
equally exposed. The B0-chain is the least exposed in all media.
All this suggests that another component in the buffer 
affects incorporation into fibrinogen and thus the molecule's 
conformation. Both the NaCl/phosphate and Tris buffers contain 
no added calcium. Consequently the effect of calcium on the 
molecule was further investigated. (See Results, Section (4)).
Table,Srivii): The Photosensitized Radioactive Labelling of IntactFibrinogen.
BUFFER INCORPORATION 
(dpm/pmole fibrinogen)
(A) 0. 13M NaCl,
6.7mM sodium phosphate, 
pH = 7.5 1041.8
(B) 0.05M Tris-HCl, 
pH = 7,5 97. 1
<C) 0.05% Tris-HCl, 
2m% CaClz, 
pH = 7.5 225.5
The above results represent the mean of six experiments.
In all cases the standard error was  ^ ±5%, and the significant difference, p, was < 0.001.
Table 3-(viil); Radioactive Labelling of The Aa, Bj3, and %-Chains ofFibrinogen.
BUFFER Aa B|3 V
(A) 0.13% NaCl,
6.7 m% sodium phosphate, 
pH = 7.5 1.7
1 1.6
(B) 0.05 K Tris-HCl, 
pH = 7.5 1.6 1 1.4
(C) 0.05% Tris-HCl, 
2m% CaClz, 
pH = 7.5 2 1 1. 1
The above results are expressed as the ratio of label incorporated by 
each chain to that incorporated by the BJ3-chain.
The figures represent the mean of six experiments. In all cases the 
standard error was ( ± 8%, and the significant difference, p, was < 0.001.
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(vi) - The next step, however, was to Investigate the 
photosensitized cross-linking patterns of fibrinogen in the 
three different buffers <ie. A, B, and C) shown in Tables 
3-Cvii) and 3-<viii). The method used is the one decribed in the 
previous chapter.
Both Laemmli (3;7%%) and SDS-polyacrylamide gels (5% and 3% 
acrylamide respectively) of the reduced and non-reduced cross- 
linked fibrinogen samples were run (see Figures 3-15 (a), (b), 
and (c)). Control gels of uncross-linked fibrinogen were also 
run in order to identify which bands are taken up by cross- 
linking.
Figures 3-15 (a) and (b) show that extensive cross-linking 
occured in the NaCl/phosphate buffer, where all three chains 
have been taken up in cross-links. However, in the Tris/CaCla 
buffer, cross-linking was less extensive. This difference was 
initially thought to be entirely due to the free radical 
scavenger effect of Tris. However, on examination of the gels 
for fibrinogen cross-linked in the Tris buffer alone, it was 
found that cross-linking was less extensive in this gel compared 
to the Tris/CaCla gel.
On examination of the 3% gels (see Figure 3-15 (c>) it was 
seen that more intermolecular cross-linking occurs in the 
Tris/CaCls buffer compared to that which occurs in both the 
NaCl/phosphate and Tris buffers respectively. All of this, plus
1 = Control (le, no cross-linking)
2 = Buffer (A): 0.13M NaCl, 6.7wK sodium phosphate, pH 7.5
3 -T Buffer (S) : 0, 05S Tris-HCl, pH 7.5
4 = Buffer (C) : 0.05H Tris-HCl, 2mM CaCl-2, pH 7.5
Figure 3-15(a): Laemmli gels (3:7fé %) of fibrinogen samples cross- 
linked under different solvent conditions, then 
reduced.
-■à
I1 = Control <ie. no cross-linking)
2 = Buffer (A): 0.13X NaCl, 6,7aM sodium phosphate, pH 7.5
3 = Buffer (B) : 0.05M Tris-HCl, pH 7.5
4 = Buffer (C): 0.05X Tris-HCl, 2mX CaCl^, pH 7.5
Figure 3-15(b): SDS-polyacrylamide gels (5% acrylamide) of fibrinogen 
samples cross-linked under different solvent 
conditions, then reduced.
IN ■
1 = Control (le. no cross-linking)
2 = Buffer (A): 0.13K NaCl, 6.7mX sodium phosphate, pH 7.5
3 - Buffer <B) : 0.05K Tris-HCl, pH 7.5
4 = Buffer (C) : 0.05N Tris-HCl, 2mK CaCl^, pH 7.5
Figure 3-15(c): SDS-polyacrylamide gels (3% acrylamide) of fibrinogen 
samples cross-linked under different solvent 
conditions.
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earlier incorporation results from the photosensitized labelling 
experiments, suggests that the molecule adopts a more open 
conformation in the presence of calcium. This phenomenom was 
further investigated (Results, Section (4>).
Full plasmin digestion of the cross-linked samples, plus 
that of a control, was then carried out according to the method 
outlined in the previous chapter. The aim of this experiment was 
to investigate whether or not the D and E domains are involved 
in the conformational changes of fibrinogen which give rise to 
the different cross-linking patterns in the three buffers.
5% SDS-polyacrylamide gels of the non-reduced samples were 
run after a digestion time of six hours at 37°C. The control gel 
pattern (resulting from the digestion of uncross-linked 
fibrinogen) showed two protein bands of fragment D and E 
respectively, indicating that the digestion had run its full 
course. The rest of the gels, representing digests of the 
various cross-linked samples, were identical to the control with 
no evidence of high molecular weight bands, thus indicating that 
no cross-linking had occured between the core domains. This 
therefore suggests that the D and E domains are not involved in 
the conformational changes which occur in the different buffers.
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j_ Ca.lci.um 5tudi.e.g-
Various investigators have shown that fibrinogen from 
several species has both high and low affinity binding sites for 
calcium (Marguerie et al, 1977; Van Ruijven-Vermeer et al, 1978; 
Kemp et al, 1983;) The importance of tightly bound calcium ions 
<Kd û: lQ-^%) to fibrinogen is well established, however the role 
of the larger number of low affinity sites (Ka - 10"®M) is less 
clear,
All results from the previous section suggest that calcium 
ions have a direct effect on the conformation of fibrinogen, 
rendering the latter more open. In addition, the results from 
both techniques correlate with each other.
The aim of this and subsequent experiments was to 
investigate fibrinogen conformation at a range of calcium 
concentrations around the physiological level. This was done via 
photosensitized cross-linking and radioactive photosensitized 
labelling.
Fhotosenal.tiag.d ..Cross-Linking.
Fibrinogen samples (concentration, 2.94 nM) were cross- 
linked for 30 seconds in 0.05% Tris-HCl, 0.05% NaCl, pH 7.5, 
containing calcium concentrations ranging from 0 to 13.5 m%. As 
seen previously, the high affinity sites are assumed to be
-74-
occupied at the "zero" calcium concentration used in these 
experiments.
3% and 5% SDS-polyacrylamide gels were then run for the non- 
reduced and reduced samples respectively.
The proportion of intermolecular cross-linking (Figure 3-16
(a)) was found to increase with an increased calcium 
concentration, This is further illustrated in Figure 3-17; here 
the 3% polyacrylamide gels were scanned and the percentage 
variation of polymer/monomer plotted against calcium 
concentration. This evidence confirms earlier results and shows 
that the fibrinogen molecule adopts a more open conformation as 
the calcium concentration is increased.
Analysis of the reduced cross-linked samples (Figure 3-16
(b)> revealed that the proportion of cross-linked Aa-chain 
increased as the calcium concentration was increased, 
particulary at calcium concentrations where there is more inter­
molecular cross-linking. On the other hand, the B|3 and %-chains 
are relatively unaffected. This suggests that the increase in 
the proportion of intermolecular cross-linking occurs mainly 
through the C-terminal portions of the Aa-chains.
The cross-linked fibrinogen samples plus a control of 
uncross-linked fibrinogen were then digested using plasmin, 
according to the method described in Chapter Two. This was done
r ■ r 1
■
#I I I
003 3-3
é.
6-7 13-3
Calcium concentration (mM)
c - control de. no cross-linking)
Figure 3-16<a): SDS-polyacrylamide gels (3% acrylamide) of fibrinogen 
cross-linked at various calcium concentrations.
1I
mm.
I I
0-03 33 13-3
Calcium concentration (mM)
c - control (ie. no cross-linking)
Figure 3-16Cb): SDS-polyacrylamide gels (5% acrylamide) of fibrinogen 
cross-linked at various calcium concentrations, then 
reduced.
100 30monomer
% polymer
90 20
80 10
700 62 4 8 10 12 14
Calcium concentration (mM)
Figure 3-17: Intermolecular cross-linking of fibrinogen as a 
function of calcium concentration.
The points represent the mean of tvo experiments.
J:Vi#l
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with the aim of investigating whether or not the D and E domains 
are involved in the calcium-induced conformational change of 
fibrinogen.
5% SDS-polyacrylamide gels of the non-reduced samples were 
run after a digestion time of six hours. Analysis of these gels 
showed that the digest products of the various cross-linked 
samples were the same as those on the control gel. There was no 
evidence of high molecular weight bands on any of the gels 
indicating that the D and E domains do not interact during the 
conformational changes which occur as a result of the influence 
of calcium.
Photosensitized Radioactive Labelling.
These experiments were carried out with the aim of 
investigating whether this technique would also detect the 
calcium-induced conformational change of the protein 
demonstrated in previous experiments.
Fibrinogen (final concentration, 1.32nM) was surface- 
labelled for 20 seconds, at a range of calcium concentrations, 
using the method described earlier. The radioactivity of the 
solubilized protein bands for gels of fibrinogen samples was 
measured by scintillation counting.
■A
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Results of the experiment can be seen in Figure 3-18. The 
latter shows that as the concentration of calcium increases, the 
amount of label incorporated into the molecule also increases. 
This corresponds to an increase in the surface area of the 
molecule exposed to solvent. These results correlate with those 
from previous experiments and reaffirm the suggestion that 
fibrinogen adopts a more open conformation in the presence of 
calcium.
The change in conformation appears to occur in two phases, 
with an increase in surface area accompanying an increase in 
calcium concentration upto 2mM and a further opening out of the 
molecule occuring above approximately 3.5mM CaCla, The 
significance of the decrease in incorporation which occurs 
between the calcium concentrations of 2-3.5mM will be discussed 
later. It should also be noted that this biphasic effect occurs 
over a range encompassing both the physiological calcium 
concentration as well as the dissociation constant of the low 
affinity calcium binding sites.
The photolabelled fibrinogen samples were then digested with 
plasmin. The aim of this experiment was to measure incorporation 
of radioactivity into the two fibrinogen core domains, D and E, 
respectively.
The labelling pattern seen in Figure 3-19 was obtained. It 
was found that the labelling of both major domains is affected,
i50r
100
50
1 4 62 5 730
Cal clum concentration (mM)
The surface labelling of fibrinogen as a function of 
calcium concentration.
The points represent the mean of two experiments.
- - # - - fi brinogeii 
— ■—  D domain
E domain150Ci
«UK0)1
100
50
0 1 2 4 63 5 7
Cal cium concentration (mM)
Incorporation of label into the D and E domains as a 
function of calcium concentration.
The points represent the mean of four experiments.
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but not identically. Incorporation into the D domains is 
influenced in both phases whereas incorporation into the E 
domain is mainly affected in the second phase.
Incorporation into the E domain does not vary much initially 
but increases as the calcium concentration is raised, This 
implies that the central or E domain of the molecule does not 
constitute a major part of its surface at the lower end of the 
calcium concentration range examined, As the concentration of 
calcium is increased, however, the E domain becomes more exposed 
and incorporation of label increases.
If the percentage of Aa-chain that is not taken up by cross- 
linking (as the calcium concentration is increased) is compared 
to the degree of labelling incorporated into the E domain (see 
Figure 3-20), it can be seen that the two are interrelated, 
Greater surface labelling of the E domain was reflected by the 
disappearance of uncross-linked Aa-chains, both effects 
increasing as the calcium concentration was raised. This 
therefore suggests that the increased incorporation into the E 
domain is due to the uncovering of this region rather than the 
effect of a conformational change occurring within the E domain.
The incorporation into the D domain is affected in both 
phases. These changes in the surface labelling of the D domains 
could be due either to conformational changes within these 
domains or to a calcium-induced exposure of these regions by
% uncross-linked Aa chain
—  E domain60
A
03!»L
30
25
20
30
20
10
0 1 2 3 64 5 7
I
Ca1 cium concentration (mM)
Figure 3-20: Relationship between B accessibility (ie. label in
E domain; dpm/pmole protein) and X uncross-linked Aa chain.
The points represent the mean of two experiments.
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some other part of the molecule. In order to distinguish between 
these possibilities, in the next experiment the effect of 
calcium on surface labelling of fragment D was compared to 
similar results for the D domain. A similar experiment was also 
carried out for fragment E and the E domain.
At this stage it is also interesting to note that when the 
sum of the incorporation into the core domains is plotted 
(Figure 3-21) the resulting trend compares very well to that of 
incorporation into whole fibrinogen. Thus, as is expected, the 
labelling of the core domains is directly reflected in that of 
the whole molecule.
In the next experiment, fragment D and fragment E 
(concentrations 2.64nM and 1.32hK respectively) were each 
labelled at a range of calcium concentrations, This was done in 
order to determine whether calcium-induced changes in the 
incorporation of the D and E domains are due to either exposure 
or conformational changes within these regions.
The results in Figure 3-22 suggest that in the first phase 
there are changes in the accessibility of the D domain. This 
area of the molecule is first made available, but is hidden 
again as the calcium concentration rises. However, in the second 
phase, although a sharp increase in the incorporation of the 
fragment occurs at approximately 3.5mM CaCla, this effect is 
somehow masked in the D domain. This suggests that despite the
fihrinogen
150
R
'M0)-P
Q)I
100
50
3 40 1 2 5 6 7
CaI cium concentration (mM>
Figure .2-21.’ Graph of the incorporation into fibrinogen and the sum of 
the incorporation into the core domains, as a function of 
calcium concentration.
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fragiænt D
- J) domain
t
100
50
0 32 41 5 76
Cal cium conceniration (mK)
Figure 3-22: Comparison of the incorporation of label into the D domain 
and fragment D as a' function of calcium concentration.
The points represent the mean of three experiments.
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increase in the incorporation of the fragment which occurs at 
this stage and upto a calcium concentration of 5mM, the D domain 
is still occluded by some other part of the molecule. The 
results thus suggest that this increase in the incorporation of 
the fragment at 3.5mM CaCla is due to a conformational change 
which renders this part of the molecule more open and thus more 
accessible to the radioactive label. The effect of this 
conformational change is somehow masked in the whole molecule.
An experiment to determine incorporation into the Aa-chains 
over a range of calcium concentrations was carried out, The 
latter was also calculated theoretically by subtracting the sum 
of the incorporation into the core domains (ie. DsE) from that 
of incorporation into whole fibrinogen. The result should 
approximate to the contribution from the C-terminal two-thirds 
of the Aa-chains. As can be seen from Figure 3-23, the 
experimental and theoretically derived values are in good 
agreement.
Definite similarities are seen when comparing the results 
for the D domain with those for incorporation into the Aa-chain 
(see Figure 3-24). Incorporation into the Aa-chain parallels 
that of the D domain. This would suggest that the Aa-chains may, 
at least in part, be responsible for the occlusion of the D 
domains.
160r
Aa chain (theoretical)
 o Aa chain (experimental)
S
100
50
2 30 4 51 6 7
Ca1 cium concentration (mM>
Elgure 2-23: Graph of incorporation of label into the Aa chains as a 
function of calcium concentration.
The points represent the mean of two experiments.
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Âa chain
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Figure 3-24: Comparison of the incorporation of label into the D domain 
and the Aa chains as a function of calcium concentration.
The points represent the mean of two experiments,
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The incorporation into the E fragment in comparison with the 
E domain can be seen in Figure 3-25. It was found that the 
overall incorporation into fragment E is much higher when 
compared to that of the domain. This suggests that fragment E 
has a very different conformation to its domainal form and thus 
the two cannot be compared directly. This was also seen when the 
experiment was performed in different buffer systems (Table 
3-ix), The high incorporation into the E fragment could be due 
to the increase in the surface area and stearic freedom of the 
fragment, compared to the rigid and tightly held domainal region 
found in the whole molecule. However, if one simply considers 
the trend of incorporation (Figure 3-25) it can be seen that, in 
general, the fragment tends to incorporate progressively more 
label as the calcium concentration is increased. However, this 
tendency is suppressed in the E domain due to occlusion by some 
other part of the molecule.
The Effegt._-Q£.-Magiiesi.um.-and.-S.Qdium Chloride on Fibrinogen
According to Marguerie at al (1977) fibrinogen has several 
binding sites of low affinity which, in the presence of 10“^M 
IfgCla are eliminated, suggesting that these binding sites are 
not specific and are due to weak interactions,
150
fragment B
-4 .—  E domain
100
60S
Calcium concentration (oK)
Figure .2.z25: Comparison of the incorporation of label into the E domain 
and fragment E as a function of calcium concentration.
The paints represent the mean of two experiments.
Table 3-(lx); Incorporation of Radioactive Label Into The E Domain 
and Fragment E.
BUFFER E DOMIir FRAGMENT E
0.05M Tris-HCl, 
2mM CaCla, 
pH = 7.5
23.8 65
0.13M HaCl,
6.7mM sodium phosphate, 
pH = 7.5 117.4 187.9
Results are expressed as dpm/pmole protein and represent the mean of six experiments.
In all cases the standard error was  ^ ± 7.5%, and the significant difference, p, was ( 0.001.
1
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The following experiments were done with the aim of 
investigating whether calcium is specifically needed for the 
conformational changes seen to occur in previous experiments.
PhQtQ.se nsi ti 2.e.d. .Cr Q.s.srLl nisi ng.
Fibrinogen samples were cross-linked in 0.05M Tris-HCl,
0.05M NaCl, pH 7.5, containing magnesium chloride concentrations 
ranging from 0 to 13.5 mM. Samples used for cross-linking at 
zero magnesium were dialysed seperately from those cross-linked 
in magnesium. Fibrinogen used in the latter experiments was 
first dialysed into the above buffer containing 0. 05mM MgCls». It 
should also be noted that the high affinity calcium binding 
sites were considered to be occupied at the zero magnesium 
concentration used in these experiments.
SDS-polyacrylamide gels of non-reduced (3% acrylamide) and 
reduced (5% acrylamide) cross-linked samples can be seen in 
Figures 3-26 (a) and (b) respectively.
The 3% gels show that to some extent the proportion of 
intermolecular cross-linking does increase with magnesium and 
therefore the latter does have some effect on the unfolding of 
the molecule. However, this effect is markedly less than that 
which occurs in calcium. The amount of polymer produced in the 
presence of magnesium starts to level off at 5mM whereas it is 
still on the increase in calcium (see Figure 3-27).
I
■ ■ ■
003 33
Magnesium concentration <oM)
133
c = control (ie. no cross-linking)
Figure 3-26(a): SDS-polyacrylamide gels (3% acrylamide) of fibrinogen 
cross-linked at various magnesium concentrations.
I I I I i I
0 03 1 3 3 5 13 3
Magnesium concentration (oM) ----►
c = control (ie. no cross-linking)
Figure 3-26 (b): SDS-polyacrylamide gels (5% acrylamide) of fibrinogen 
cross-1 inked at various magnesium concentrations, then 
reduced.
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'#---- % polymer (Ca)
% polymer (Ng)
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Ca / Mg concentration (mK)
Figure Comparison of the effect of calcium / magnesium on
intermolecular cross-linking.
The points represent the mean of two experiments,
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This is also reflected in the 5% gels (see Figure 3-26(b)) 
where the resulting number of cross-linked bands are less in 
magnesium compared to those for the calcium experiment (see 
Figure 3-16(b)). It should also be noted that the Aa-chain is 
the one decreasing in intensity compared to the BJ3 and %-chains 
which remain relatively unaffected. This suggests that the Aa- 
chain is still the first subunit to be taken up in cross- 
linking.
The aim of the aodl.um chloride experiments was to see if any 
other ion, such as sodium, has an effect on the conformation of 
fibrinogen.
Fibrinogen was cross-linked in 0.05M Tris-HCl, containing 
sodium chloride concentrations ranging from 0 to 40mM. (Ionic 
strength differences were compensated for). Gels of non-reduced 
and reduced cross-linked samples were run on 3% and 5% 
acrylamide gels respectively (see Figures 3-28 (a) and (b)).
Intermolecular cross-linking patterns on the 3% gels showed 
that although dimer formation did result, not only was this the 
only cross-link band seen, but the amount of dimer formed was 
minimal compared to the amount of polymer formed in the calcium 
experiment. The maximum amount of dimer present on the gel 
representing the highest sodium chloride concentration was 5.5%.
h
0 2 5
Sodium chloride concentration (mM/3)
133
c = control (ie. no cross-linking)
Figure 3-26 (a): SDS-polyacrylamide gels (3% acrylamide) of fibrinogen 
cross-linked at various sodium chloride concentrations.
N iI
i
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003 33 13-3
Sodium chloride concentration (oM/3)
c - control (ie. no cross-linking)
Figure 3-28(h): SDS-polyacrylamide gels (5% acrylamide) of fibrinogen 
cross-1 inked at various sodium chloride concentrations, 
then reduced.
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The cross-linking patterns on the 5% gels showed that no 
increase in the amount of cross-linked bands occurred over the 
range of sodium chloride concentrations. The extent of cross- 
linking is also minimal and there is no appreciable decrease in 
the intensity of either of the Aa, B)3 or %-bands over the range 
of sodium chloride concentrations tested.
Radi pact i ve . Photoseasi t ized. .Lab.el.llng.
The aim of these experiments was to investigate the effect 
of magnesium and sodium chloride on the radioactive 
photosensitized labelling pattern of fibrinogen. The results 
obtained were then compared to those resulting from calcium 
studies.
Fibrinogen was surface labelled in 0.05M Tris-HCl, 0.05% 
NaCl, pH 7.5, containing magnesium chloride concentrations 
ranging from 0 to 13.5m%. The result of this experiment (Figure 
3-29) shows that although magnesium has a similar effect to 
calcium in that the molecule adopts a more open conformation, 
higher magnesium concentrations are required to produce 
equivalent effects.
Fibrinogen was then photolabelled in sodium chloride over a 
similar range of ionic strengths. The results (see Figure 3-30) 
show that sodium chloride has no effect in rendering the 
conformation of fibrinogen more open.
150
d)
100
50-
3 54 60 2 71
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Figure 3~29: Comparison of the effect of calcium / magnesium on the 
photosensitized radioactive labelling of fibrinogen.
The points represent the mean of two experiments.
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Figure 3-30; Comparison of the effect of calcium / sodium chloride on 
the photosensitized radioactive labelling of fibrinogen.
The points represent the mean of two experiments.
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The aim of this work was to develop and assess the two 
techniques of photosensitized radioactive surface labelling and 
photosensitized cross-linking with a view to examining the 
conformation of fibrinogen in its native state and under 
different solvent conditions, with particular reference to the 
influence of calcium.
Prior to carrying out the above studies, the primary concern 
was to isolate a stable fibrinogen preparation from human 
plasma. The two main priorities concerning this step were that 
the fibrinogen had to be of good quality (ie. with a high degree 
of intactness) and free of contaminating proteins. These two 
points are very important in view of the fact that this study is 
primarily concerned with the shape of the molecule.
Normal human plasma contains fibrinogen of different 
molecular weights. Mills and Karpatkln (1971) suggested that 
this heterogeneity was due to the proteolytic action of thrombin 
on the molecule, On the other hand, Mosesson et al (1974) 
attributed this heterogeneity to in vivo degradation of the Aa- 
chain by plasmin, whilst Semeraro et al (1977) proposed that the 
majority of Aa-chain heterogeneity is the result of storage of 
plasma which leads to in vitro cleavage of this subunit.
Phillips (1981) developed a method to isolate and separate two 
molecular sizes of fibrinogen, FI (high molecular weight form) 
and FIX (lower molecular weight form), which had been found by
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Lipinska et al (1974). The difference between these two forms 
lies in their respective Aa-chain content. SDS-PAGE of FII 
showed that this contains only one intact Aa-chain. On the other 
hand Holm and Godal (1984) used fibrin to exclude non-clottable 
proteins from their preparations and demonstrated that normal 
plasma fibrinogen contains three major fibrinogen fractions 
which differ in molecular weight. The HM¥ fraction (molecular 
weight 340,000) contains intact Aa-chains while the molecular 
weight of fractions LMV and LMV' is reduced to 305,000 and 
270,000 respectively due to proteolysis of the C-termlnal parts 
of one (LMV), or both (LMV*), Aa-chains (Holm et al, 1985a).
The most important conclusion that can be drawn from these 
studies is that the Aa-chain represents a highly labile portion 
of the molecule. Variations in this subunit's molecular weight 
probably represent a combination of in vivo and in vitro 
cleavage; thus a good course of action for purifying fibrinogen 
would be to adopt as rapid a procedure as possible so as to 
minimize in vitro cleavage. Plasmin contamination of the 
fibrinogen preparation must also be avoided.
In view of the fact that fibrinogen binds calcium and that 
it is resistant to dénaturation (Ly and Godal, 1973) and 
digestion (Marguerie, 1977; Haverkate and Timan, 1977;) in the 
presence of calcium, and also because a major part of this study 
concerns the influence of calcium on the structure and 
properties of fibrinogen, a purification procedure where calcium
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is included, was selected. Due to this inclusion, however, a 
preparation free of prothrombin and factor XIII is required.
This is so since calcium ions accelerate activation of 
prothrombin to thrombin and the latter converts fibrinogen to 
fibrin. Thrombin and calcium ions are also involved in the 
activation of the proenzyme, factor XIII, to its active form, 
factor XIIla, by the removal of a short peptide (Lorand and 
Konishi, 1964). The function of factor Xllla is to cross-link 
and stabilize fibrin covalently via the formation of isopeptide 
bonds in the final step of fibrin formation and this stage also 
requires the presence of calcium ions. Thus for these reasons 
calcium should be left out of buffers used until prothrombin is 
removed from the system. Several proteins, including 
prothrombin, tend to co-precipitate with fibrinogen and 
therefore specific techniques must be included in the 
purification of the molecule in order to remove such 
contaminants quickly and efficiently.
In this study, purification was carried out by a method 
adapted from that of Lawrie et al (1979). By means of this 
method both fibrinogen and plasminogen (and consequently the 
core fragments D and E) can be purified from the same plasma 
sample. Plasminogen is removed from plasma by passing the latter 
over a lysine-sepharose column; here plasminogen (or plasmin) 
attaches to the lysine groups on the column, in preparation to 
be displaced at a later stage by e-amino caproic acid. 
Prothrombin is removed from the plasminogen-free plasma by the
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additlan of an aluminium hydroxide suspension onto which it is 
absorbed.
Various procedures may be used to precipitate fibrinogen 
out of solution, including salt or organic solvent 
fractionation. The latter method is based upon differences in 
the solubility of proteins in aqueous solutions of such organic 
solvents as ethanol, acetone, butanol or, as Kekwick et al 
(1955) used, ether. (The latter method is the one used by 
authors Pouit et al (1972), Hudry-Clergeon et al (1975), and 
Marguerie and Stuhrmann (1976). - (See Chapter One, Table 1- 
(iv), and later in this chapter). However such solvents may 
cause dénaturation which results in changes in the molecule's 
conformation. Consequently in this method salt fractionation, 
involving the use of ammonium sulphate, was used to precipitate 
out fibrinogen.
After dialysis the suspended precipitate is applied to a 
DBAE-cellulose column. It is important to note that only at this 
stage is calcium introduced into the buffer system. Three peaks 
are eluted off the column using buffers made progressively more 
concentrated in HaCl. Peak I fibrinogen has a lower negative 
charge compared to the peak II type and thus elutes first. As 
judged by gel electrophoresis, peak I fibrinogen shows little 
degradation compared to that contained in peak II and 
constitutes the more intact fraction. Factor XIII is also 
eluted in peak II. The third peak (III) contains fibronectin
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which is known to associate with fibrinogen. Thus in this case 
ion exchange chromatography serves two main purposes; (i) the 
separation of fibrinogen types on the basis of their intactness, 
and (ii) the removal of remaining co-precipitating protein 
contaminants. In the studies to follow, only peak I fibrinogen 
was used. The method of purification described here allows the 
isolation of high quality fibrinogen in under eight hours.
The core fragments D and E were prepared from the purified 
fibrinogen using a by-product of the above method, ie. 
plasmin(ogen), according to the procedure described in Chapter 
Two. The digestion was done in the presence of calcium <lmM), as 
the result of a report by Haverkate and Timan (1977) who found 
that D(cate) (ie. the final fragment D product with calcium 
present) is protected from further plasmin attack in the 
presence of calcium. (N.B. As stated earlier, from here on this 
fragment will simply be referred to as fragment D). This system 
also approximates physiological conditions with respect to the 
calcium concentration. The digest mixture was then applied to a 
DEAE-cellulose column. The first peak to elute (peak (i>) is 
fragment D which passes straight through, The remaining protein 
(peaks (ii) and (ill)) was eluted using a sodium chloride 
gradient of 0 to 0.5 H NaCl, to displace fragment B off the 
column. Peak (ii) contains a mixture of fragments D and E, 
whilst peak (ill) contains fragment E alone.
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The next stage of these studies was the development of the 
two selected modes of investigation, ie. photosensitized 
radioactive surface labelling and photosensitized cross-linking. 
First of all, a set of conditions were established for the 
optimization of either method which led to consistent and 
reproducible results. Both methods have certain advantages in 
that they are carried out in solution, the initiation and 
duration of the reaction can be easily controlled, and the 
processes occur via highly reactive, short-lived, intermediates.
Initial photolabelling experiments showed that the binding 
of the radioactive tryptophan label to the protein could be 
induced by illumination in the presence of fluorescein. It was 
also shown that the linkage between the protein and label is 
covalent since bound label cannot be removed by, for example, 
dialysis, SDS-polyacrylamlde gel electrophoresis, or 
dénaturation by 8X urea. However, as seen previously (Chapter 3) 
photosensitized labelling studies also showed that a side- 
reaction which competes with the labelling occurs. Singlet 
oxygen generated when fluorescein is irradiated with near UV 
light reacts both with amino acid residues on the polypeptide 
chains of the protein as well as with the free C =^H3tryptophan in 
solution. The latter is converted to a free radical and reacts 
with the protein surface; covalent bonds are formed and the 
amount of radioactive tryptophan bound can be calculated. This 
information indicates which parts of the molecule are exposed to 
solvent and are therefore surface-orientated. However covalent
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bonds between protein and free tryptophan are not the only ones 
that result from this reaction, protein-protein cross links are 
also generated. Thus in the case of labelling studies conditions 
have to be optimized such that the photolabelling reaction is 
the predominant one oocuring. This involves such measures as 
decreasing the amount of protein used and decreasing irradiation 
time. The degree of cross-linking can easily be monitored by 
examining the protein on SDS-polyacrylamide gels.
However the potential of the cross-linking reaction itself 
was also realized and this technique was used independently as a 
means of studying the molecule's conformation. The technique of 
fluorescein-activated cross-linking follows similar chemistry 
and uses similar apparatus to the technique of photosensitized 
radioactive labelling with one major difference, - no free 
tryptophan is added to the system. . Consequently the singlet 
oxygen transfers its energy only to protein molecules which then 
form cross-links with any other protein Cintermolecular cross- 
linking), or part of the same protein (intramolecular cross- 
linking). The cross-links are very short in length and thus 
cross-linked species must have been in very close proximity 
originally. Intramolecular cross-links occur within the molecule 
itself and provide information regarding the orientation of the 
chains. Intermolecular cross-links occur between protein 
molecules and provide information regarding surface orientation 
of the actual chains.
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Once the main problems in the methodology had been tackled 
and overcome and the experimental conditions established, the 
next step was to investigate the photosensitized labelling and 
cross-linking of both fibrinogen and Its plasmin derivatives, 
fragments D and E, under various conditions, with particular 
reference to the influence of calcium. However, prior to 
discussing the results, a comprehensive review of the different 
methods which have been used by various authors for the purpose 
of this investigation and the suggested models to date, (as 
outlined briefly in Chapter One), is necessary to bring this 
work into perspective.
There has been considerable controversy over the years 
regarding the conformation of fibrinogen. Intact fibrinogen does 
not crystallize and therefore definitive X-ray crystallographic 
analysis has not yet been carried out. Crystals have been 
produced after limited cleavage of the molecule by a bacterial 
protease such as that from Pseudonomas aeruginosa (Tooney and 
Cohen, 1972), however this in itself suggests that the authors 
were examining a molecule which had undergone a significant 
conformational change. Consequently, most of the information 
regarding the shape of the molecule has been obtained by 
electron microscopy or physiochemical analysis.
Electron microscopic observations of fibrinogen have led to 
the proposal of several structural models ranging from an 
elongated trinodular structure, Hall and Slayter (1959), to a
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spheroidal shape, Koppel (1966) (see Figure 4-1), Hall and 
Slayter carried out their studies by imaging individual 
fibrinogen molecules that had been sprayed on mica in a volatile 
buffer, dried in vacuum, and shadowed with heavy metal. They 
proposed that the fibrinogen molecule consists of a linear array 
of three nodules held together by a very thin thread, the two 
end nodules being similar to each other but slightly larger that 
the central one. Most of the data from biochemistry and physical 
chemistry fits this model, however much controversy arose from 
laboratories attempting to visualise the molecules by negative 
staining which is generally recognised as a higher resolution 
technique than shadowing, Large globular particles were the 
predominant species found in these specimens (Koppel, 1966;
Pouit et al, 1972;) and led Koppel to name the structure he 
observed a pentagonal dodecahedron. Pouit et al also suggested, 
however, that the globular model they put forward had the 
ability to unfold to a more rod-like structure under different 
physical conditions such as activation by thrombin or other 
agents.
Support for either of these two main models arose from a 
number of workers using various techniques and include refined 
versions of the two proposed conformations.
In 1979, Fowler and Erickson attempted to establish the 
correct model for the structure of the fibrinogen molecule by 
using their improved methods for both shadow casting and
47 5 1 2*5 nm
<1*5 nm
6*5 nm i4— 65 nm fe—5nm k—
HalJ and Slayter (1959)
2 3 nm
Koppel (1966)
Figure 4-1: Proposed models of fibrinogen conformation by Hall and 
Slayter (1959) and Koppel (1966).
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negative staining in the same study. In the shadow casting 
technique, glycerol was included in the buffer in which the 
protein was sprayed onto the mica. It was found that in the 
absence of glycerol the protein was deposited in aggregrates or 
the molecular structure distorted by drying; in the presence of 
glycerol, however, most of the droplets had clean areas of 
unaggregated molecules. With respect to the negative staining 
technique, the authors found that the standard carbon films used 
were very hydrophobic and the stain would not spread unless the 
fibrinogen solution was applied at high protein concentrations, 
leading to the random aggregration of molecules. In order to get 
the negative stain to spread and stick to the carbon film at low 
protein concentrations, the authors used a surface of the film 
that had been rendered hydrophilic by the "flotation technique" 
(see reference) and were thus able to prepare specimens at 
concentrations of l-5pg/ml, 1000 times less than those used in 
the previous studies of Koppel (1966) and Pouit et al (1972).
The end result showed that molecules examined by either method 
had a trinodular structure of dimensions very similar to those 
of Hall and Slayter, (ie, length = 45nm ± 2.5nm, outer nodule 
diameter = 6-7nm, central nodule diameter = 4-5nm). The authors 
also suggest that globules seen in various negative staining 
studies are aggregates of these molecules. This point had also 
been suggested by Krakow et al (1972). The work of Williams 
(1981,1983), who used electron microscopy after contrast 
enhancement by rotary shadowing and negative staining to examine
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the conformation of fibrinogen, also showed the molecule to have 
a trinodular structure.
Even though digestion of fibrinogen by the action of 
Pseudonomas proteases on the Aa-chain results in crystals of the 
partially degraded molecule, the overall structure seen by 
electron microscopy images and X-ray crystallography is 
basically trinodular (Veisel et al, 1981, 1985; Cohen et al, 
1983).
One of the strongest arguments in favour of the trinodular 
model comes from the asymmetric cleavage model by plasmin 
digestion (Harder et al, 1969), The authors purifed the various 
digest fragments and their physiochemical and immunological 
properties were defined; they found that the core fragments D 
and E correspond to the outer and central nodules respectively, 
fragment Y is binodular comprising one D and one E, and 
fragment X is a trinodular molecule missing the carboxyl- 
terminal segment of the Aa-chain. These findings were also 
confirmed by electron microscopic analysis of the fragments 
(Fowler et al, 1980; Adams-Lucas et al, 1983;) where the 
relationship of each plasmin cleavage fragment to the trinodular 
model of Hall and Slayter was defined. A number of other 
laboratories have used electron microscopy of antibody-labelled 
fibrinogen as a method of investigation. Telford et al (1980) 
used antibodies to the disulphide knot fragment (H-D8K) of 
fibrinogen in combination with metal shadowing to locate its
/•. .. *£ . ■ Ui-
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site within the intact molecule and concluded that this lies 
within the central nodule of the trinodular model. Price et al
(1981) localized the D and E domains in the outer and middle 
regions of the trinodular fibrinogen molecule respectively, 
using specific anti-D and anti-E Fab fragments in metal shadowed 
specimens. Similar results were also reported by Horton and 
Slayter (1981).
The model of Doolittle et al (1977) also supports the 
trinodular conformation. This was generated by computer 
simulation based on both primary structure data and by taking 
into account the evolutionary perspective (see Figure 4-2). 
Basically the model consists of two terminal domains tethered to 
a central domain by two three-stranded ropes thought to be in 
the form of coiled coils in which the non-polar residues are 
turned inwards and the polar side chains extend out into the 
aqueous solvent (Doolittle et al, 1978); the C-terminal parts of 
the Aa-chains are freely arranged in space. The model was 
originally (1977) drawn with a bend because of the presumed 
parallel nature of the disulphide bonding between the two 
dimeric halves, similar to the situation found in 
immunoglobulins. However in the light of the work of Hoeprich 
and Doolittle (1983), who determined that the two %-chains, and 
hence the dimeric halves, were connected in an anti-parallel 
manner, this constraint was lifted. This model thus leaves the 
question of the molecule's flexibility open to speculation.
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The question of the flexibility of fibrinogen molecules is 
still an issue. It is not hard to envisage that one or more of 
the components of this multidomainal structure can bend or twist 
independently to other parts of the molecule. Various 
experimental data, including electron microscopy and 
immunochemical studies, has been put forward which supports the 
concept of a flexible fibrinogen conformation.
Bachmann et al <1975), in a study of freeze-etched 
fibrinogen, proposed a cylindrical, rod-like molecule with 
rounded ends, 45nm ± l.Snm long and with a diameter of 9nm ±
Inm. These dimensions are roughly compatible with the trinodular 
model, though this technique apparently lacks sufficient 
resolution to identify the individual domains. Approximately 30% 
of the observed molecules were bent to various degrees, giving 
the structure a certain degree of flexibility. Estis and 
Haschemayer (1980) also reported that fibrinogen (negatively 
stained with sodium phosphotungstate) had the form of a 
flexible, indistinctly beaded rod, having a nodular 
configuration when observed unstained.
Mosesson et al (1981) investigated the conformation of 
fibrinogen by evaluating scanning electron microscopic images of 
the molecule. Their findings were consistent with the trinodular 
structural model (length = 46nm ± 2nm), however it was also 
suggested that the molecules are flexible and may exist in 
unfolded configurations or as relatively compact, partially or
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cQmpletely folded forms. Further studies by this group (Vail et
al, 1983) yielded similar results.
The proposed model of Hudry-Clergeon et al (1975), based on
the results of co-workers Pouit et al (1972), is that of a non­
compact sphere, 22nm in diameter, very similar to that of 
Koppel. These workers proposed that the constituent chains of 
the molecule fold around the H-terminal disulphide knot and are 
stablized by intramolecular reactions of an electrostatic 
nature. However it was also suggested that the latter 
interactions could be modified by enzymatic peptide cleavage or 
by the action of certain paracoagulant factors, thus allowing 
the uncovering of sites involved in fibrin polymerization and 
cross-linking and giving the molecule a certain amount of 
flexibility. It was suggested that the globular shape only 
persists in the first aggregation stages of fibrin formation and 
the structure of the fibrin monomer included in the fibrin fibre 
is less connected with the one of the native fibrinogen 
molecule. The workers maintained, however, that the spherical 
shape would be predominant in physiological conditions (see 
Figure 4-3).
Marguerie et al (1975) and Marguerie and Stuhrmann (1976) 
were the first to investigate the structure of fibrinogen by 
neutron small angle scattering. The resulting structure from the 
analysis pattern in terms of multipoles was consistent with that 
of an ellipsoid or flattened disc, more graphically termed as
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the '‘banana-shaped' model. The authors proposed the possible 
localization of three structurally important zones as well as 
flexible zones within the molecule. The model agrees with the 
concept of a highly hydrated protein, - 6g H^O/g protein was the 
estimated degree of hydration. On the basis of this work the 
authors also suggested that the bent structures observed by 
Bachmann et al (1975) represented the native form of fibrinogen 
rather than denatured molecules and that Koppel (1966), using 
the negative staining method, had observed loosely packed 
flattened discs rather than spheres (Marguerie, 1979).
From his small angle X-ray scattering data Lederer (1979) 
suggested that, in fact, fibrinogen is a highly flexible 
'sausage-like' molecule (45nm long, 9nm wide) not having just 
one specific conformation. The author also proposed that the 
disc-like model of Marguerie and Stuhrmann (1976) merely 
represents one specific conformation of this highly flexible 
molecule. Serralach et al (1979) attempted to reconcile 
experimental and calculated hydrodynamic data with electron 
microscopic models of fibrinogen. These workers found poor 
agreement between the two, even if the degree of hydration was 
varied upto 9g HsO/g protein. However agreement was achieved by 
assuming a highly flexible molecule. The idea of flexibility was 
further postulated by Hantgan (1981,1982) in his conformational 
studies of fibrinogen in solution using steady-state fluoresence 
polarization. His results Indicate that fibrinogen is not a 
rigid molecule, but can undergo bending or twisting motions in
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solution, and strongly support some kind of segmental 
flexibility within the molecule.
Plow and Bdgington (1982) used specific antibody probes to 
investigate the surface topography of fibrinogen in its native 
state. The described epitopes were superimposed on the 
trinodular model proposed by Doolittle et al (1977) and it was 
found that these were better accommodated by a more flexible 
model, or 'flexion', in which the D and E domains could 
associate. The authors suggested an equilibrium between flexed 
and linear formats, with only the latter conformation capable of 
fibrin polymerization.
As well as the flexibility of the molecule, another issue 
regarding the conformation of fibrinogen is the spatial 
arrangement and role of the C-terminal parts of the Aa-chains.
Doolittle et al (1979) divided the amino acid sequence of 
the Aa-chain into three zones, namely ZM, ZM and ZC. These 
correspond to the amino-terminal third (residues 1 - 239), the 
middle third (residues 240 - 424), and the carboxyl-terminal 
third (residues 425 - 610) of the Aa-chain respectively. A short 
subzone (constituting part of the ZN region, ie. residues 195 - 
239) was designated IZ. Residues 1 - 8 2  and 105 - 200 of the ZM 
region correspond to segments of the Aa-chain found in the E and 
D domains respectively (Henschen et al, 1982).
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In the model of fibrinogen postulated by Doolittle et al
(1977) the C-terminal parts of the Aa-chains are freely arranged 
in space (see Figure 4-2), This suggestion is supported by Price 
et al (1981) who, however, used Fab fragments of antibodies 
specific only for the ZM portion of the Aa-chain in their 
investigation. From this work these authors intrepreted their 
results as showing these portions of the Aa-chain and (by 
inference) also the C-terminal parts, to be situated beyond the 
outer domains of the molecule, at a considerable distance from 
the central domain. From observations derived using a novel 
electron microscope specimen preparation technique, Rudee and 
Price (1981) also suggested that the Aa C-terminal extensions 
protrude away from the D domains of the molecule. On the other 
hand, Telford et al (1981), using antibodies to fragment H of 
fibrinogen (which roughly corresponds to the ZM portion of the 
Aa-chain), found that this is located on the surface of the 
intact molecule, in association with the D domain.
However in 1981 the investigations of Mosesson et al led to 
the suggestion of another model which, although similar to that 
of Doolittle, differs in the spatial arrangement of the 
C-terminal parts of the Aa-chains. The authors suggested that 
the latter regions of these chains are situated within the mass 
integration radius for the central domain. Thus, in this model, 
the C-termini of the Aa-chains protrude from the outer domains 
and extend towards the central domain by winding around the long 
axis (see Figure 4-4). This view is supported by the fact that
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this structural feature is observed In negatively stained 1-4 
fibrinogen preparations but not in 1-9 where the C-terminal 
parts of the Aa-chains are removed.
From their calorimetric study of the melting of fibrinogen 
and its fragments, Privalov and Medved' (1982) showed that parts 
of the native molecule which were removed in the early stage of 
its proteolytic degradation have a cooperative structure which 
melts on heating, with a noticeable heat effect. This effect was 
not seen in the melting profile of the X fragment when compared 
to that of intact fibrinogen. Further calorimetric work carried 
out by Medved' et al (1983) supports the model put forward by 
Mosesson and goes further to state that the C-terminal parts of 
the Aa-chains form two structural domains which strongly 
interact with each other in the region of the central domain of 
the molecule, probably by means of some complimentary surface 
sites. Computer analysis of the amino acid sequence of the 
C-terminal two-thirds of the Aa-chain (ie. residues 200 - 610) 
showed that a-helix and conformation are quite probable in the 
390 - 550 residue section of the considered polypeptide, while 
the 250 - 390 residue section is likely to be in random 
conformation. The association of these two structural domains 
results in what can be termed as the ‘fourth domain' of 
fibrinogen.
Erickson and Fowler (1983), using electron microscopy, also 
observed the existence of a fourth nodule <5nm in diameter) in
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the fibrinogen molecule, which is located near the central 
domain, lOnm away on one side of the molecular axis. Since the 
nodule was never observed for the X fragment, the authors 
suggested that it is formed by the C-terminal portions of the 
two Aa-chains.
Cierniewski et al (1984) investigated the conformation of 
the C-terminal regions of the Aa-chains by immunochemical 
analysis. The authors found that epitopes expressed by the 
intact Aa-chain, which were occult in the native molecule, 
became accessible when fibrinogen was cleaved with plasmin. The 
authors thus proposed that their results are consistent with 
structural models depicting the C-terminal portions of the Aa- 
chain as being systematically ordered in the native fibrinogen 
molecule. Significantly, the authors suggested that the 
existence of such ordering introduces a new variable into 
regulation of the many functions of this region of the molecule,
Veisel et al (1985) also demonstrated the existence of the 
fourth domain. These authors showed that molecules modified for 
crystallization by limited cleavage with a bacterial protease 
retained the main features of the native structure. However the 
major difference between the modified and native fibrinogen was 
the loss of a small central domain which they suggest is formed 
by the C-terminal portions of the Aa-chains folding back to 
interact at the centre of the molecule.
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There are a number of possible reasons for the plethora of 
models put forward, one being that investigation of the 
structure was done using a wide variety of techniques. Electron 
microscopy generally involves rigid preparative procedures which 
may affect the native conformation of fibrinogen. Artefacts 
easily occur using this method and differences in the procedure 
used greatly influence the state in which fibrinogen is 
observed. On the other hand, workers using physiochemical 
analysis as a tool for investigation may have obtained over­
simplified results since the effects of different regions of the 
molecule are usually averaged out in the interpretation, thus 
leading to ambiguity. Different methods of fibrinogen 
purification were also implemented by the various workers, thus 
resulting in fibrinogen species of different intactness and 
quality for examination.
Bang (1964) and Krakow et al (1972) also showed that the 
fibrinogen molecule exhibited an abnormally high degree of 
hydration and this could explain some of the differences in 
results obtained by the various methods. Different degrees of 
hydration could have resulted in different interpretations to 
fit either of the two diametrically opposed models. Hydrodynamic 
and solution data can fit either model: if the molecule is a 
narrow or trinodular structure 45nm long it will be a relatively 
compact protein, whereas if the molecule is a sphere 20nm in 
diameter, it must be very highly hydrated (approximately 8g HaO 
per g protein).
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However another very important source of differences is the 
influence of the particular enviroment on the molecule's 
conformation. Each investigation was usually carried out at 
fixed conditions of, for example, buffer and pH, and thus the 
resulting structure holds true only for the parameters under 
which the experiment was performed. Hudry-Clergeon et al (1975) 
proposed that the fibrinogen molecule could exist under 
different balanced forms, the relative properties of which 
depend on various factors such as temperature, pH, ionic 
strength, solvent nature and protein concentration. Another 
group of workers, Mueller and Burchard (1978), investigated the 
structure of fibrinogen using light scattering. Although they 
found that under the fixed conditions in which their experiments 
were carried out the molecule appeared to have a rod-like 
conformation, the authors postulated that fibrinogen can exist 
in different interchangeable isomeric forms such as a folded rod 
similar to that of Bachmann et al (1975) and the banana-shaped 
model of Marguerie et al (1975) (see Figure 4-5). More 
importantly, however, these authors suggested that the 
predominant isomer would be dependent on its enviroment, with 
special emphasis on the influence of calcium. The importance of 
calcium on the structure of fibrinogen has also been emphasised 
by Kemp (1984). The author suggested that since fibrinogen is 
able to bind calcium ions with both high and low affinity and 
that these ions are important to the integrity of the molecule, 
work done in the absence of calcium may not yield a valid 
interpretation of the structure.
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A = structure similar to the model of Marguerie et al, <1975).
B = structure similar to the model of Bachmann et al, <1975).
C ~ rod-like conformation observed by Mueller and Burchard <1978)
Figure 4-5: Different isomeric structures of fibrinogen suggested by 
Mueller and Burchard <1978).
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The Importance of calcium on the structure and function of 
fibrinogen has been investigated by a number of authors whose 
work will be discussed in the course of this chapter. An example 
of one such study is that carried out by Larsson et al <1987), 
who studied fibrinogen by means of dynamic laser light 
scattering. Their results suggest that fibrinogen expresses a 
certain degree of flexibility in the absence of added calcium 
(but where calcium high affinity sites have not been vacated), 
whereas it is straightened or unfolded when calcium is added to 
the system. More specifically the authors proposed that when no 
calcium is present fibrinogen resembles a folded rod, similar to 
the structure of a disc and not unlike the proposed oblate 
ellipsoid model of Marguerie and Stuhrmann (1976); however in 
the presence of calcium the molecule unfolds to a straight rod 
structure or prolate ellipsoid similar to that observed by 
Bachmann et al (1975). Larsson et al also suggested that as 
calcium is known to enhance the rate of fibrinogen to fibrin 
formation, this stabilization of the fibrinogen molecule by 
calcium may be relevant for enhancement of the polymerization 
rate. This may by brought about, for example, by exposure of 
polymerization sites in the molecule.
In the studies presented in this work, fibrinogen and its 
derivative core fragments were examined under different solvent 
conditions so as to test the premise put forward by various 
authors that the molecule is a flexible one, existing in 
different isomeric forms. The importance of tightly bound
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calcium ions to fibrinogen has been investigated (Marguerie et 
al, 1977), but the role of the larger number of low affinity 
sites is still not clear. Consequently the conformation of the 
molecule was examined with particular reference to the influence 
of calcium.
Preliminary experiments suggested that fibrinogen is a 
molecule whose conformation is influenced by its enviroment.
This effect was seen when the protein was found to be more open 
and thus more prone to interaction with other molecules in the 
Tris/CaCla buffer compared to the Tris and MaCl/phosphate 
buffers (all at pH 7.5). This effect was observed as a result of 
using both photolabelling and cross-linking techniques. The 
presence of calcium was found to be a major cause in the 
unfolding of the molecule.
When the distribution of label into the three constituent 
chains of fibrinogen (Aoc ; Bj3 : V) was calculated for the above 
buffers, results showed that in both MaCl/phosphate and Tris 
buffers the Aa and %-chains are equally exposed. However in the 
Tris/CaCla buffer the Aa-chain is the most surface-orientated 
and takes up almost as much label as the Bj3 and %-chains 
combined. This enhanced surface-orientation of the Aa-chains in 
the presence of calcium suggests that this conformational change 
may be linked to this particular part of the molecule having 
some functional role under the conditions described.
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Results derived from cross-linked fibrinogen in the three 
different buffers correlate with those obtained from labelling 
experiments. Here calcium was seen to increase the cross-linking 
potential of the molecule since intermolecular cross-linking is 
more extensive in the Tris/CaClœ buffer compared to both Tris 
and KaCl/phosphate buffers. This opening up of the molecule 
brought about by calcium is similar to the effect first 
suggested by Pouit et al (1972), ie. that the molecule ’unfolds' 
under certain solvent conditions. Larsson et al (1987) showed 
that calcium plays a key role in this conformational change; 
this view is consistent with the results presented in this work. 
In addition, analysis of gels (5% acrylamide) of reduced 
fibrinogen after cross-linking showed that the Aa-chain is the 
subunit which is taken up by cross-linking the most rapidly.
This correlates with photoaffinity labelling results where the 
Aoc-chain was seen to be the most surface-orientated of the 
chains in the presence of calcium, and would thus be the most 
likely subunit to be taken up in cross-links first. Full 
digestion of the cross-linked samples showed that the D and E 
core domains are not involved in the conformational changes seen 
to occur in the different buffers.
It is widely known that calcium is important to the 
structural integrity and function of fibrinogen. As seen 
earlier, calcium ions bind to fibrinogen (Marguerie et al,
1977), stabilize it against dénaturation by heat (Ly and Godal,
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1973) and acid (Marguerie, 1977), and limit its digestion by 
proteases such as plasmin (Haverkate and Timan, 1977).
Various authors have also shown that calcium ions accelerate 
the conversion of fibrinogen to fibrin by increasing the rate of 
fibrin polymerization. (Boyer et al, 1972; Endres and Scheraga, 
1972; Brass et al, 1978;). The importance of calcium in fibrin 
formation has also been studied by Hardy et al (1983). These 
authors suggested that high-affinity bound calcium forms an 
integral part of the fibrinogen structure while free calcium 
ions have a regulatory role in fibrinogen conversion to fibrin 
by modulating the rate of polymerization and not that of 
fibrinopeptide cleavage.
Okada and Blomback (1983) demonstrated that calcium ions 
have a pronounced effect on fibrin gel structure. The authors 
showed that the rigidity of the gel is increased when it is 
formed in the presence of calcium, In addition, the authors 
suggested that this structural change is explained by the 
binding of calcium to low affinity sites on fibrinogen or the 
fibrin monomer/polymer. The authors also found that although 
magnesium Interacts with fibrinogen, its effect is different 
from that exerted by calcium. Although magnesium decreases the 
clotting time of the gel-forming system, no effect on the 
k«(permeability coefficient) values of the fibrin gels formed in 
the presence of this ion was seen.
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Ruf et al (1986) showed that calcium ions do not Influence 
the release of fibrinopeptides A and B in the initial enzymatic 
phase of the reaction. However during subsequent polymerization, 
desA-fibrin polymers formed in the presence of calcium ions 
represent better substrates than those formed in the absence of 
calcium for the proteolytic attack of thrombin on the B^-chain. 
The authors suggested that this can be explained either by an 
accelerated formation of fibrin oligomers in the presence of 
calcium, or by formation of different oligomers due to calcium 
ions serving as a better substrate for the attack of thrombin on 
the Bj3-chain.
In addition, as seen earlier on in this chapter, calcium 
ions are essential for the activity of factor XIII in fibrin 
cross-linking. (Lorand and Konishi, 1964; Curtis et al, 1974;).
From the information already gathered as a result of this 
study it can be seen that fibrinogen is a dynamic molecule whose 
flexibility is influenced by the presence of calcium. The two 
techniques of photosensitized radioactive labelling and 
photosensitized cross-linking have been shown to have definite 
applications in their use as probes into the conformation of the 
molecule. Results derived from the above methods of 
investigation are not only reproducible but also support one 
another. The next set of experiments was done to investigate the 
effect of calcium on the molecule in greater detail. The range 
of calcium concentrations selected encompassed both the
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physiological level (ie. approximately 10~®M) and the 
dissociation constant of the low affinity binding sites 
(Kd 10-=M).
Results derived from gels of cross-linked fibrinogen showed 
that the amount of intermolecular cross-linking increased with 
an increase in the calcium concentration. This implies that 
fibrinogen is more compact at lower calcium concentrations and 
therefore less prone to contact with other molecules. Analysis 
of gels of reduced, cross-linked, fibrinogen showed that the 
increase in the proportion of intermolecular cross-linking 
occurs mainly through the Aa-chains. Thus one can visualize the 
unfolding of the molecule due to the influence of calcium, with 
the C-terminal portions of the Aa-chains playing a leading role 
in the formation of intermolecular links.
This conclusion is supported by results from further work 
done in our laboratory where fibrinogen was progressively 
digested to fragment X and then cross-linked at intermediate 
stages (Webster, 1987). In this experiment the amount of 
intermolecular cross-linking decreased as the digestion 
progressed and did not occur to any significant extent with 
fragment X.
In this study, the samples cross-linked at the different 
calcium concentrations were then fully digested in order to 
investigate whether the core domains are involved in the
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observed conformational changes. From the resulting gel patterns 
it was concluded that the D and E domains do not interact as a 
result of the influence of calcium.
The flexibility of fibrinogen and the effect calcium has on 
the molecule's conformation was also seen in the photolabelling 
experiments. As the concentration of calcium is increased in the 
millimolar range, the amount of label incorporated into the 
molecule increases, suggesting that fibrinogen adopts a more 
open conformation in the presence of calcium. The change in 
conformation occurs over a range encompassing both the 
physiological calcium concentration and the dissociation 
constant of the low affinity binding sites. The saturation of 
these sites is therefore important and, as has been suggested by 
various authors, may have a regulatory function. The effect is 
biphasic with an increase in surface area accompanying an 
increase in calcium concentration up to 2mM (phase I) and a 
further unfolding of the molecule occuring above approximately 
3.5mM CaCla (phase II). The dip in incorporation which occurs 
between the two phases (from here on referred to as the 
'intermediate' phase) has its own significance and will be 
discussed later.
Digestion of photolabelled fibrinogen to the core domains, D 
and E, showed that the labelling of the terminal and central 
domains is affected but not identically. Incorporation into the 
D domains is influenced in both phases and dips in the
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intermediate phase, whereas that of the E domain is mainly 
affected in phase II. As expected, the sum of the labelling of 
the core domains is also directly reflected in that of the whole 
molecule.
The results show that the E domain does not constitute a 
major part of the molecule's surface at the lower end of the 
calcium concentration range examined. However as the calcium 
concentration is increased, incorporation into the E domain also 
increases. This could be due either to a conformational change 
within the domain or to its uncovering by movement of some other 
part of the molecule.
Two regions of the molecule that may possibly occlude the E 
domain are (a) the D domains or (b> the C-terminal portions of 
the Aa-chains. Digest patterns of cross-linked fibrinogen 
indicated that the D domains are not directly involved in 
calcium-induced conformational changes of the molecule. However 
if the percentage of Aa-chain that is not taken up by cross- 
linking is compared to the degree of labelling incorporated into 
the E domain, it can be seen that the two are interrelated. 
Greater surface labelling of the E domain was reflected by the 
disappearance of uncross-linked Aa-chains, both effects 
increasing as the calcium concentration was raised. This 
suggests that increased incorporation into the E domain is due 
to the uncovering of this region by the C-terminal parts of the
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Aa-chains, rather than the effect of a conformational change 
occuring in the domain.
Thus from the results presented it is suggested that at low 
calcium concentrations the C-terminal parts of the Aa-chains are 
in close association with the central domain. This correlates 
well with the work of Mosesson et al (1981), Medved' et al 
(1983), and Erickson and Fowler (1983) regarding the spatial 
arrangement of the C-terminal portions of the Aa-chains in the 
native fibrinogen molecule. It should also be noted, however, 
that none of the above authors used buffers containing added 
calcium in their investigations. Consequently it can be assumed 
that the low affinity calcium binding sites of fibrinogen were 
not saturated in the above studies.
The ordered arrangement of the C-terminal parts of the Aa- 
chains raises the question of the functional role of this 
dimeric block. It is widely known that fibrinogen interacts with 
other plasma proteins and particles. The C-terminal regions of 
the Aa-chains contain several sites of interaction: other 
molecules involved include fibronectin (îïosher, 1975) and factor 
XIII (Credo et al, 1981), as well as platelets (Hawiger et al, 
1982). Proteolytic damage to C-terminal portions of the Aa- 
chains also leads to the disruption of normal fibrin 
polymerization (Phillips, 1981). Clot opacity studies by the 
latter author suggest that this region of the molecule plays an
-114-
Important role in lateral associations during fibrin 
polymerization.
Holm et al (1985b) also found that the C-terminal of the a- 
chain is important for fibrin polymerization. Their 
investigation of the plasma fibrinogen fractions HHW (molecular 
weight: 340,000, containing intact Aa-chains) and LMW (molecular 
weight; 305,000, containing just one intact Aa-chain) showed 
that HMV fibrin momomers polymerize at a higher rate than LMW 
monomers. The prolonged clotting time of LMW was found to be due 
to retarded polymerization and not to the enzymatic phase of 
coagulation (measured as release of fibrinopeptide A during 
incubation with thrombin), The authors also found that both 
types of monomer polymerize more rapidly in the presence of 
calcium.
Medved' et al (1985, 1986), however, proposed an additional 
role for the dimeric block they had observed in their earlier 
studies (1983), ie. that the Aa domains participate in fibrin 
polymerization not as structural components, but as a factor 
promoting the ordered process of fibrin assembly (see Figure 
4-6). On the basis of their experimental evidence from electron 
microscopy and light scattering, the authors suggested that 
interactions between aC-domains can occur intermolecularly as 
well as intramolecularly and that the former predominate in 
monomeric fibrin compared to fibrinogen. The C-terminal parts of 
the Aa-chains are thus thought to dissociate from each other
(a)
(b)
<a) = fibrinogen
<b> = monomeric fibrin
(c) - the protofibril
aC-domains are denoted by black; the main active sites of 
the central (B) and peripheral (D) domains are shaded.
Figure 4-6 ; The role of the aC-domains in fibrin assembly.
(Medved' et al, 1986).
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during fibrin formation, thereby acting as 'antennae' to help 
promote the rapid finding and oriented mutual approach of other 
fibrin monomers. This permits the main polymerization sites 
present in the central and peripheral domains to interact 
rapidly and accurately in the construction of protofibrils. In 
addition, the authors also suggested that the aC-domains 
accelerate lateral aggregation of the protofibrils in the second 
stage of fibrin polymerization. The results presented in this 
thesis support this hypothesis and further propose that calcium 
ions are the cause of the dissociation of the intramolecular Aa 
domain. This is so since, as demonstrated in the results, as the 
calcium concentration is increased, the dissociation of the 
fourth domain is triggered, thus enabling the E domain to 
incorporate more radioactive label.
Apart from its role in fibrin polymerization, this proposed 
activation of the molecule by calcium has several implications 
when the other functions of the Aa C-terminal regions are 
considered. It may well be that the Aa fourth domain occludes 
crucial sites of interaction and that calcium may be the factor 
required to 'activate' these sites by its effect on the 
dissociation of the Aa domain.
One of the molecules involved in the interaction of the 
C-terminal regions of the Aa-chains is factor XIII'. Credo et al
(1978) showed that fibrinogen enhances the generation of 
fibrinoligase activity by lowering the calcium requirement of
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the thrombin-modified factor XIII zymogen (ie. factor XIII*, or 
a*aba). The addition of a physiologically equivalent 
concentration of fibrinogen promoted the conversion of factor 
XIII* to the functionally competent enzyme factor XIIla (ie. 
aa*) at physiological calcium concentrations. In the absence of 
fibrinogen approximately 6  - lOmM Ca+^ would be needed to 
achieve the same effect, The authors later suggested (1981) that 
fibrinogen thus functions as a physiologically important 
calcium-modulator protein. These workers showed that the 
critical interaction domain for contact with factor XIII* 
corresponds to a stretch of residues in the middle section (ie. 
residues 243 - 476) of the Aa-chain of fibrinogen. Proteolytic 
damage to C-termlnal portions of the Aa-chains leads to a loss 
in the ability of fibrinogen to accelerate the activation of 
factor XIII*.
Fibronectin (otherwise known as 'cold-insoluble globulin') 
is a large glycoprotein (molecular weight; 440,000) comprising a 
dimeric molecule with carboxyl termini linked in the central 
region by a disulphide bond, and an amino terminus at each end 
of the strand. Purified fibronectin is always found to contain a 
small amount of fibrinogen as a contaminant or co-purifying 
species. Mosher (1975) showed that factor XIIla cross-links 
fibronectin to fibrin or fibrinogen and demonstrated that 
attachment was to the a-chain of fibrin. (The cross-link 
acceptor site on fibronectin was identified as a glutamine, 
three residues from the amino terminus of the chain). In
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addition it was found that fibrinogen loses its ability to bind 
to fibronectin if the C-terminal parts of the Aa-chains are 
damaged (Stahakis et al, 1978). Niewiarowska and Cierniewski
(1982) also reported that the incorporation of fibronectin into 
fibrin is not only dependent on fibronectin concentration and 
temperature, but also on the presence of millimolar calcium.
The interaction of fibrinogen with specific receptors on the 
surface of the activated platelet results directly in platelet 
aggregation. Binding occurs only when platelets are stimulated 
with certain agonists such as ADP, epinephrine and thrombin. The 
native structure of fibrinogen is also a prerequisite for 
optimal binding and aggregation and it has been shown that 
fragment X digests are less potent in supporting aggregation 
compared to fibrinogen (Niewiarowski et al, 1977). The presence 
of calcium, necessary for receptor regulation and receptor- 
ligand interaction, favours the specific conformation for 
optimal function.
Three different fibrinogen domains have been implicated in 
the fibrinogen-platelet interaction, namely the amino terminal 
regions of the Aa and Bj3-chains, the carboxyl terminal regions 
of the %-chalns, and the carboxyl terminal regions of the Aa- 
chains. The involvment of the latter domain is of specific 
relevance to the studies presented in this work.
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Hawiger et al (1982) reported that aggregates of the Aa- 
chain support ADP-induced platelet aggregation. In addition, 
Marguerie et al (1984) found that photoactivation of fibrinogen 
(which had been modified with the heterobifunctional reagent, 
SAMAH, ie. ÎT-succinimidyl-6 - (4*-azido-2'-nitrophenylamino) 
hexanoate)) caused the protein to become covalently bound to the 
platelet through the carboxyl terminal regions of the Aa-chains. 
Fibrinogen missing the extreme carboxyl termini of the Aa-chains 
failed to cross-link to platelets efficiently under similar 
conditions, indicating that the integrity of this region of the 
chain is essential for cross-linking to occur. The authors also 
showed that the Aa-chain comes into close proximity to the 
platelet membrane glycoprotein Ilb/IIIa complex on binding to 
the platelet. The implication of the involvement of the latter 
heterodimer complex in fibrinogen receptor function was also 
demonstrated by Bennett et al (1982).
Divalent ions are necessary for binding to occur. Fujimura 
and Phillips (1983) found that the membrane glycoproteins lib 
and Ilia exist as a complex in vivo and that this is regulated 
by the presence of calcium ions. In addition, Phillips and 
Baughan (1983) found that fibrinogen binding to platelets was 
optimum at 10~"^M calcium. It is interesting to speculate that 
since, as seen in these studies, calcium has been shown to 
trigger the dissociation of the fourth domain, the presence of 
this divalent ion may thus be necessary to uncover sites of
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Interaction on the Aa-chains which are involved in platelet 
interactions.
The influence of calcium was also seen to affect the 
incorporation of label in other parts of the fibrinogen 
molecule. Incorporation into the D domain is affected in both 
phase I and II, with a decrease in incorporation occuring in the 
intermediate phase. This incorporation profile could be the 
result of either conformational changes occuring within the 
domain or to uncovering /covering of the domain by some other 
part of the molecule. In order to distinguish between the two, 
the effect of calcium on the surface labelling of fragment D was 
compared to results for the D domain.
Results showed that in phase I the available surface of the 
D domain increases, but that it decreases in the intermediate 
phase. The available surface of this region of the molecule then 
remains steady in the first part of the second phase but slowly 
increases again as the calcium concentration is raised further. 
On the other hand, incorporation into fragment D is relatively 
constant upto approximately 3.5mM CaClz, indicating that any 
changes in the incorporation of the domain upto this calcium 
concentration are not conformational but are due to uncovering 
(phase I) and covering (intermediate phase) of this region by 
some other part of the molecule (or molecules). However although 
a sharp increase in the incorporation of the fragment occurs in 
the second phase, (at a concentration of approximately 3.5mM to
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5mM CaClæ), incorporation in the D domain is relatively constant 
indicating that this region is still occluded at this stage.
Thus the conformational change that occurs in the fragment, 
which renders this region of the molecule more open and thus 
more accessible to radioactive label, is masked in the D domain 
due to this region's occlusion by some other part of the 
molecule.
This observed calcium-induced conformational change is in 
accordance with the findings of several authors. As seen 
previously, Mosesson et al (1981) investigated the structure of 
fibrinogen by scanning transmission electron microscopy and 
results from this study were consistent with tridomainal 
structural models. However the authors found that the outer 
terminal domains of negatively stained molecules could be 
resolved into at least two discrete subdomains forming an oblong 
structure, usually at an angle of 120° - 150* relative to the 
long axis (see Figure 4-4). Williams (1981) also observed these 
oblong terminal protrusions (length = 9nm; width = 4nm) of the |
molecule in his electron microscopy studies, however the angle j
Iof attachment to the long axis was seen to be more acute ie. \
45°. More interestingly, however, the author also found that j
after exposure of the fibrinogen molecules to millimolar
calcium, each terminal domain took on the form of two contiguous |
equal-sized spheres (diameter = 4nm). Thus, in the absence of J
calcium, the material in the subdomains was found to partially j
overlap onto each other whereas in the presence of millimolar 1
1
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calcium the material in each subdomain remains separate, 
resulting in two spherical globules. Consequently the overall 
effect of calcium on the D domain seems to be the dissociation 
or unfolding of the two comprising subdomains.
Mihalyi and Donovan (1985) also reported a calcium-induced 
conformational change within the D domain, as a result of their 
findings from calorimetric studies. The authors suggested that 
there must be at least two different kinds of unfolding units in 
the D nodule.
The enhancing effect of calcium on the fibrin polymerization 
process can be explained in part by this conformational change
in the D domain leading to an Increased affinity of jI
polymerization sites within this domain for corresponding j
t
complementary sites in the E domain,
Doolittle (1973) proposed that the release of fibrino- ?
peptides from the central domain allows intermolecular contact 
between the latter and the terminal domains of other molecules |
during polymerization. In 1978 Laudano and Doolittle found that Ii
short peptides beginning with the sequence Gly-Pro-Arg (glycine- |
proline-arginine), corresponding to the first three amino acids |
iof fibrin a-chains exposed by release of fibrinopeptide A, can j
bind to fibrinogen and prevent the polymerization of fibrin |
monomers. The same authors also showed (1980) that peptides
beginning with the corresponding j3-chain sequence, Gly-His-Arg- I
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Pro (His = histidine) also bind to fibrinogen, albeit at 
separate sites, but do not prevent polymerization. Gly-Pro-Arg- 
Pro binds to both sets of sites, although less tightly to the 13- 
chain type. Both types of peptide were found to bind to the 
fragment D portions of fibrinogen.
Further studies by Laudano and Doolittle (1981) into the 
influence of calcium on the binding of fibrin amino terminal 
peptides to fibrinogen showed that the affinity of the amino 
terminal tetrapeptide of the #-chain of fibrin for fibrinogen 
increases in the presence of calcium; conversely no increase in 
the affinity of the corresponding a-chain peptides beginning 
with the sequence Gly-Pro-Arg was seen, although the number of 
binding sites did increase. (The latter was found to be due to 
binding of the a sequence to the #-chain site). The authors thus 
proposed that since the presence of calcium increases the 
affinity of Gly-His-Arg-Pro almost ten-fold, this indicates that 
the true physiological circumstances surrounding fibrin 
formation require the presence of calcium ions.
Furlan et al (1983) showed that the binding of calcium to 
low affinity sites on the molecule induces a conformational 
change in fibrin monomers. The ability of the peptide Gly-His- 
Arg to bind to fragment D thus increases, thereby accelerating 
the polymerization process.
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The next investigation in these studies was concerned with 
determining which part (or parts) of the molecule is responsible 
for occlusion of the D domain. The calculation of experimentally 
and theoretically-derived values for incorporation of label into 
the Aa-chains as a function of calcium concentration were found 
to be in good agreement with each other. When these were 
compared to incorporation into the D domain it was found that 
the two parallel each other. This strongly suggests that certain
regions of the Aa-chains are at least partly responsible for
occlusion of the D domain.
The rise and fall of the incorporation into the D domain and
Aa-chains in the first and intermediate phases (respectively) 
could be the result of intermolecular cross-linking occuring at 
this range of calcium concentrations. It is thus suggested that 
the Aa-chains dissociate intramolecularly as the calcium 
concentration is raised. The D domain is progressively 
uncovered, and both D and Aa regions incorporate more label. 
Intermolecular cross-linking similar to that suggested by 
Medved' et al (1986) can then occur, as a consequence of which 
both Aa-chain and D domainal regions are occluded. This results 
in a decrease in the radioactivity incorporated by both regions 
and the degree of incorporation levels off at this stage.
This sequence of events which is seen to occur as the 
calcium concentration is raised also correlates well with the 
observed conformational change in D. As seen previously, the
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proposal presented in this study, ie. that the Aa-chains act as 
'antennae' in fibrin formation, agrees with that of Medved' et 
al (1986). However from the results presented here it is further 
suggested that calcium ions not only trigger the dissociation of 
the Aa C-terminals, but also effect a conformational change in 
the D domain. Thus, as Aa intermolecular bonds are formed, 
conformational changes in the terminal domains occur, This 
renders the D domains more accessible and prone to 
intermolecular contacts, such as those that are made in the 
polymerization of fibrin monomers to protofibrils ie. DD-long 
and DE-stag contacts.
The presence of calcium is known to accelerate the formation 
of a fibrin clot from fibrinogen in the presence of thrombin. 
Thus, by extension, calcium-dependent conformational changes in 
the Aa C-terminals and D domains presented in this study may be 
at the basis of some of the events occuring in fibrin 
polymerization. It is thus suggested that calcium plays a role 
in stabilizing the fibrinogen molecule in a conformation that is 
favourable for its function in polymerization. However for these 
events to be linked directly to fibrin formation, fluctuations 
in the calcium concentration must occur in the microenviroment 
surrounding the forming fibrin clot. As seen previously, the 
amount of free calcium ions present in blood plasma is lO-^M; 
the dependence on calcium for many of the events occuring in the 
coagulation cascade (Figure 1-1) has also been shown. When the 
wall of a blood vessel is transected, the collagen in the
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vascular wall is exposed to the blood, and platelets immediately 
adhere to the exposed collagen fibres. These platelets then 
release calcium, 5-hydroxytryptamine, ADP, ATP and pyrophosphate 
simultaneously. If platelet calcium was equally distributed 
throughout the cell, its concentration would be approximately 
30mM (Mills and Macfarlane, 1976); thus it is quite possible 
that the release of such calcium stores could cause fluctuations 
in the calcium concentration of the microenviroment immediately 
surrounding the forming blood clot, thus creating favourable 
conditions for calcium-dependent conformational changes in 
fibrinogen to occur.
It is interesting to note that this proposed mechanism can 
be paralleled to that which has been suggested for the 
activation of factor XIII at the site of clot formation (Curtis 
et al, 1974). As seen earlier. Credo et al (1978, 1981) reported 
that fibrinogen enhances the generation of fibrinoligase 
activity by lowering the calcium requirement of the thrombin- 
modified factor XIII zymogen (factor XIII') from 6  ~ lOmM, to 
physiological calcium concentrations. Thus at normal plasma 
concentrations of free calcium, thrombin and calcium alone 
cannot activate the enzyme, - fibrinogen is also required. 
However Curtis et al (1983) suggested that it is feasible for 
thrombin and calcium alone to activate factor XIII at the site 
of coagulation due to the elevated calcium concentration 
resulting from this ion's release by platelets.
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Calclum was not the only divalent ion whose effects on the 
structure of fibrinogen were investigated in this study: 
magnesium and sodium chloride were also compared to calcium 
chloride. In Godal*s (1960) studies on the effect of the anti­
coagulant EDTA on human fibrinogen, the author reported that all 
effects of EDTA could be corrected by calcium while magnesium 
was much less effective. Marguerie et al (1977) showed that 
whereas the three high affinity binding sites of fibrinogen are 
specific for calcium, the low affinity sites are eliminated in 
the presence of 10~^M magnesium chloride. The authors suggested 
that these are not specific and are due to weak interactions.
Cross-linking results showed that although magnesium does 
have some effect on the unfolding of the molecule's 
conformation, this does not occur to the same extent as that 
seen to result in the presence of calcium. This was also 
reflected in photolabelling experiments where higher magnesium 
concentrations were needed to bring about effects similar to 
those brought about by calcium. It was seen that within the 
range of magnesium concentrations investigated (ie. equivalent 
to those of calcium used), only phase I and the intermediate 
phase resulted. In the presence of calcium phase I occurs over 
the 0 - 2mM range whereas this is extended to 5mM in the 
presence of magnesium chloride. Thus higher magnesium 
concentrations are required to produce equivalent calcium 
effects; consequently these appear to be * delayed' in magnesium. 
The conformational changes resulting in magnesium are very
-127-
likely to be due to the divalent ion binding to low affinity 
sites on fibrinogen, as reported by Marguerie et al (1977). 
However from the results seen in this study it is suggested that 
these sites do have a certain degree of specificity for calcium 
since the latter ions are more effective in bringing about 
conformational changes in the molecule compared to magnesium 
ions.
The effect of sodium chloride was also compared to that of 
calcium and magnesium chloride at an equivalent range of ionic 
strengths. From both cross-linking and photolabelling results it 
was apparent that sodium chloride has a negligible effect on the 
conformation of fibrinogen.
Thus, in this study, the two techniques of photosensitized 
radioactive surface labelling and photosensitized cross-linking 
have been developed and have also been shown to have definite 
applications in their use as probes into the conformation of 
fibrinogen. The results derived using these methods primarily 
support the view put forward by various authors that fibrinogen 
is a dynamic molecule having a flexible conformation and that 
the conformation adopted is dependent on solvent composition. 
Calcium concentration in the millimolar range is particularly 
significant and consequently so is the saturation of low 
affinity calcium binding sites which may well have a regulatory 
function. It is therefore suggested that fibrinogen is a dynamic 
isomer, with the predominant form at any one time being
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dependent on certain physiological parameters, one major factor 
being calcium concentration. A possible suggestion concerning 
this point is that this change in the isomeric form of the 
molecule, which is under the control of physiological 
parameters, may be due to fibrinogen conforming to a specific 
structure where it becomes more feasible for a particular enzyme 
to act, according to the body's requirements at that particular 
point in time,
Experimentally, two extreme conformations have been 
demonstrated, - a closed compact structure at low calcium 
concentrations compared to a more open one at higher calcium 
concentrations. More importantly, however, the methods used also 
show the subtle changes which occur within the molecule as the 
calcium concentration is raised, changes which may be more 
significant physiologically. The most significant of these are 
the effects of calcium on the C-terminal parts of the Aa-chains 
and the D domains.
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